Does coping style moderate the relationship between irritable bowel syndrome related stressors and psychological distress in a clinical IBS population? by Markow, Christine Joy
                                                   
                                                                                                                                                                        
 
 
 
 
           
Does Coping Style Moderate the Relationship between Irritable Bowel Syndrome  
     Related Stressors and Psychological Distress in a Clinical IBS Population? 
 
     
  
                            A Thesis  
                Submitted to the Faculty 
                      of  
                                                          Drexel University  
                                                                      by 
                                                   Christine Joy Markow, M.S.  
                                                    in partial fulfillment of the  
                                                   requirements for the degree 
                                                                      of 
                                                        Doctor of Philosophy 
                                                                June 2006 
           
 
                                                                                                 
  ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         
  
                                                         © Copyright 2006 
                                       Christine J. Markow.  All Rights Reserved. 
   
 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                 
  iii 
                                                       DEDICATIONS 
I dedicate this to my mother and father, Diane and Harry Markow, whose 
unconditional love, friendship, humor, and support has guided me through this 
journey towards the light at the end of the tunnel.  For all of your love, support, and 
guidance, I thank you with all of my heart.   
 
To my grandparents: Harry Sr. & Josephine Markow, Frances Masny and in loving 
memory of my grandfather Joseph Masny.  Without a lifetime of hard work, love and 
dedication to family, I would not be here. 
 
I further dedicate this to persons who have sustained a spinal cord injury.  “Challenge 
yourself, push all limits to the edge, go beyond what you thought possible, or more 
importantly, what others say is completely impossible.  Remember, no matter what 
there is always a side door.” –Christine J. Markow- 
  
 
 
 
 
 
 
                                                                                                 
  iv 
                                                  ACKNOWLEDGMENTS 
This dissertation would not have come to light without the generosity of many key 
individuals.  I am truly grateful for Dr. Andrew T. Fanelli and his medical staff for 
welcoming me into the Regional Gastrointestinal Consultants, providing me with office 
space and allowing me to meet patients and collect data at his center.  Additionally, I 
sincerely thank my dissertation committee members, Dr. Andrew T. Fanelli, Lamia 
Barakat, Ph.D., Pamela Geller, Ph.D., and Todd Lewis, Ph.D. for their time and 
valuable contributions.  My deepest appreciation is extended to Jacqueline D. Kloss, 
Ph.D., who has provided guidance and support throughout this process, serving not only 
as my dissertation chair, but also as my mentor.  
 
I further would like to express gratitude to Sondra Solomon, Ph.D. who has served as 
a teacher, friend, and inspiration both personally and professionally.  To Ed DeMet, 
Ph.D. whose spirit, knowledge, guidance, and kindheartedness gave me the 
confidence to complete my dissertation.  Finally, I am grateful to all the persons who 
volunteered their time and shared their precious experiences with me, enabling me to 
conduct research in the unique and delicate area of irritable bowel syndrome. 
 
 
 
 
                                                                                                 
  v 
TABLE OF CONTENTS 
LIST OF TABLES...................................................................................................x 
LIST OF FIGURES ............................................................................................... xi 
ABSTRACT.......................................................................................................... xii 
1.     INTRODUCTION ..........................................................................................1 
2.     IRRITABLE BOWEL SYNDROME .............................................................5 
         2.1 Description ...............................................................................................5 
          2.2 Patient Profiles on Characteristics and Predictors of IBS .......................7 
                   2.2.1 Incidence and Prevalence ............................................................7 
                   2.2.2 Age ..............................................................................................8 
                    2.2.3 Gender.........................................................................................9 
                    2.2.4 Abuse History ...........................................................................10 
          2.3 Diagnosis of Irritable Bowel Syndrome ................................................13 
                   2.3.1 Manning Criteria........................................................................14  
                   2.3.2 Rome Criteria.............................................................................15 
          2.4 Irritable Bowel Syndrome and Functional Disorders ............................16 
          2.5 Current Treatments for IBS ...................................................................17                                   
                    2.5.1 Medical Treatment ....................................................................17 
                    2.5.2 Medications...............................................................................18 
                    2.5.3 Psychosocial Treatment of IBS.................................................19 
          2.6 Pathophysiology of IBS .........................................................................21 
                                                                                                 
  vi 
                    2.6.1 Deregulation of the Nervous System ........................................21 
                    2.6.2 The Brain-Gut Axis...................................................................23 
3. STRESS........................................................................................................28 
          3.1 Definition ...............................................................................................28 
          3.2 Current Stress Research .........................................................................33 
4.      PSYCHOLOGICAL DISTRESS..................................................................37 
          4.1 Definition ...............................................................................................37 
          4.2 Psychopathology, Distress, and IBS ......................................................40 
                  4.2.1 Albany Studies ............................................................................41 
          4.3 IBS Related Symptoms and Distress .....................................................41 
5. COPING........................................................................................................46 
          5.1 Theoretical Approaches to Coping ........................................................46 
          5.2 Definition ...............................................................................................47 
          5.3 Coping Research ....................................................................................49 
          5.4 Literature Review Summary ..................................................................51 
6.     THE PRESENT STUDY ...............................................................................55 
          6.1 Hypotheses.............................................................................................56 
                    6.1.1 Hypothesis 1..............................................................................56 
                    6.1.2 Hypothesis 2..............................................................................56 
                    6.1.3 Hypothesis 3..............................................................................57 
7. METHOD........................................................................................................58 
                                                                                                 
  vii 
          7.1 Participants.............................................................................................58 
          7.2 Procedure ...............................................................................................60 
          7.3 Measures ................................................................................................61
                    7.3.1 Coping.......................................................................................61 
                    7.3.2 Distress......................................................................................62 
                    7.3.3 Anxious Symptoms...................................................................63 
                    7.3.4 Stressors ....................................................................................64 
                    7.3.5 Perceived Stress ........................................................................65 
                    7.3.6 Demographic Sheet...................................................................66 
8.     DATA ANALYSIS........................................................................................67 
          8.1 Hypothesis 1...........................................................................................69 
          8.2 Hypothesis 2...........................................................................................69 
          8.3 Hypothesis 3...........................................................................................70 
          8.4 Data Reduction.......................................................................................71 
9. RESULTS........................................................................................................72 
          9.1 Descriptive Statistics..............................................................................72 
          9.2 Bivariate Analysis of Independent and Dependent Variables. ..............72 
          9.3 Analysis of Multicollinearity and Potentially Confounding  
                Variables ................................................................................................73 
 
          9.4 Relationship between Symptom Severity and Distress .........................74 
          9.5 Relationship between Active Coping, Irritable Bowel Syndrome, and 
                Distress...................................................................................................75 
                                                                                                 
  viii 
          9.6 Relationship between Avoidant Coping, Irritable Bowel Syndrome, and 
                Distress...................................................................................................77 
 
          9.7 Post-Hoc .................................................................................................... 
 9.7.1 Relationship between IBS Symptom Severity and  
        Depression................................................................................79 
 
 9.7.2 Relationship between Active Coping, IBS Symptom  
        Severity and Depression ..........................................................80 
 
 9.7.3 Relationship between Avoidant Coping, IBS Symptom  
        Severity and Depression ..........................................................81 
 
 9.7.4 Relationship between IBS Symptom Severity and  
          Trait Anxiety............................................................................81 
 
 9.7.5 Relationship between Active Coping, IBS Symptom  
        Severity and Trait Anxiety.......................................................82 
 
 9.7.6 Relationship between Avoidant Coping, IBS Symptom  
        Severity and Trait Anxiety.......................................................83 
 
                     9.7.7 Gender Comparisons................................................................83 
10.     DISCUSSION..............................................................................................85 
          10.1 Demographics ......................................................................................89 
          10.2 Stressors and Distress ..........................................................................93 
          10.3 Coping Style and Distress....................................................................97 
          10.4 Moderational Effects............................................................................99 
                    10.4.1 Active Coping, IBS Symptom Severity and Distress .............99 
                    10.4.2 Avoidant Coping, IBS Symptom Severity and Distress .......101 
          10.5 Limitations .........................................................................................103 
                                                                                                 
  ix 
          10.6 Implications and Future Research......................................................105 
11.     SUMMARY AND CONCLUSION ..........................................................107 
LIST OF REFERENCES.....................................................................................109 
APPENDIX A: Manning Criteria ........................................................................121 
APPENDIX B: Rome Criteria I...........................................................................122 
APPENDIX C: Rome Criteria-II .........................................................................123 
APPENDIX D: The Enteric Nervous System......................................................124 
APPENDIX E: Model of Moderation .................................................................125 
APPENDIX F: The COPE Scales........................................................................126 
APPENDIX G: DSM-IV-TR Criteria of Substance Abuse .................................127 
APPENDIX H: IBS Symptom Severity Scoring System ....................................128 
APPENDIX I: Perceived Stress Scale .................................................................132 
APPENDIX J: Demographic Sheet .....................................................................133 
VITA....................................................................................................................153                   
 
  
 
 
  
 
 
                                                                                                 
  x 
                                               LIST OF TABLES 
 
1. Descriptive Statistics for Independent and Dependent Variables....................136  
2. Intercorrelations between Independent and Dependent Variables...................137 
3. Intercorrelations between Demographic and both  
     Independent and Dependent Variables ...........................................................138 
 
4. Coefficients of Regression of Distress on Stressors 
    (PSS and IBS-related) ......................................................................................139 
 
5. Coefficients of Regression of Distress on Stressors  
    (PSS and IBS-Related) and Active Coping Style ............................................140 
 
6.  Coefficients of Regression of Distress on Stressors  
     (PSS and IBS-Related) and Avoidant Coping Style .......................................141 
 
7.  Variance and Significance of Regression of Depression, State and Trait 
     Anxiety on Stressors (PSS and IBS-Related), and Coping Style  
     (active and avoidant).......................................................................................142 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                 
  xi 
LIST OF FIGURES 
 
 
1. A diagram of the Brain-Gut Axis (Mayer & Collins, 2002)..............................23 
 
2. Process model of the stress/ health relationship based on the Transactional 
     Stress Theory (Lazarus, 1991) ..........................................................................30 
 
3. Frequency Table of Irritable Bowel Symptom Severity in a Clinical IBS 
    Population (N=98) ...........................................................................................143 
 
4. Frequency of Perceived Stress in a Clinical IBS Population (N=98) ..............144 
 
5. Correlation between IBS Symptom Severity and Distress ..............................145 
 
6. Correlation between Avoidant Coping and Distress........................................146 
 
7. Correlation between Active Coping and Distress............................................147 
 
8. Frequencies of active coping by gender (N=98)..............................................148 
 
9. Regression Equations for the Relationship between IBS Symptom Severity  
    and Active Coping on Distress ........................................................................149 
 
10. The Relationship between IBS Symptom Severity  
      and Active Coping on Distress ......................................................................150 
 
11. Regression Equations for the Relationship between IBS Symptom  
      Severity and Avoidant Coping on Distress....................................................151 
 
12. The Relationship between IBS Symptom Severity and  
      Avoidant Coping on Distress .........................................................................152 
 
 
 
 
 
 
  
                                                                                                 
  xii 
  
                                                              
                                                           ABSTRACT 
       Does Coping Style Moderate the Relationship between Irritable Bowel Syndrome  
            Related Stressors and Psychological Distress in a Clinical IBS Population? 
                                                Christine J. Markow, M.S 
                                                  Jacqueline D. Kloss, Ph.D. 
 
 
 
Irritable Bowel Syndrome is the most common of the functional gastrointestinal 
disorders and frequently viewed as a significant physical and psychological stressor 
in one’s life.  The current study explored the relationships between irritable bowel 
syndrome related stressors, psychological distress (i.e., anxious and depressive 
symptoms), and coping style in a clinical irritable bowel syndrome population.  
Ninety-eight persons diagnosed with irritable bowel syndrome completed self-report 
questionnaires.  Results indicated that irritable bowel syndrome related stressors and 
perceived stress were significantly associated with psychological distress.  
Furthermore, it was found that both active and avoidant coping styles moderated the 
relationship between stressors and distress in this population.  The clinical and 
research implications of this study are discussed. 
                                                                                                                    
   CHAPTER 1: INTRODUCTION 
 
 Throughout history, writings of physicians and historians suggest 
functional gastrointestinal (GI) disorders have existed, but lack of an identifiable 
cause has prevented their categorization as diseases.  This unidentifiable organic 
cause may have made diagnosis and treatment “second class” in medical school, 
residency teaching and research.  Until the middle of the twenty-first century, 
when systematic investigation began, only occasional reports of these disorders 
existed.  Scientific attention to understand and care for patients with functional GI 
disorders has developed over the past 20 years and grown progressively in the 21st 
century.  Reasons for increased interest in functional GI symptoms may be that 
irritable bowel syndrome (IBS) symptoms are viewed as a syndrome that has 
treatment options and the use of new investigative techniques in the 
gastrointestinal physiology field.  Given their significant impact on health care, 
investigation into the classification, pathophysiology, and treatment of functional 
GI disorders is warranted.  Additional research on functional GI disorders is 
needed in order to train both physicians and psychologists to adequately care for 
this population. 
 Research on the psychological aspects of functional GI disorders has 
yielded three general observations.  First, perceived stress generally exacerbates 
GI symptoms (Drossman, 2003).  Second, psychological disturbances amplify 
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illness experience and adversely affect health status (Trikas et al., 1999).  Third, 
having a functional GI disorder may significantly impair the quality of one’s life 
though IBS symptom experience and ambiguity of treatment options (Petrak, 
2001). 
 One evolving theory by Burnett and Drossman (2005) suggests chronic GI 
symptoms are generated by a combination of intestinal motor, sensory and central 
nervous system (CNS) activity that they termed the “Brain-Gut Axis.”  The 
mechanism for these associations provides a bi-directional relation between 
sensation in the gut (upper &lower intestines) and intestinal motor function.  
External stressors and cognitive information (i.e., emotion, thought) have, by 
nature of their neural connections in the brain, the capability to affect GI 
sensation, motility, and secretion (Laughlin, 2000).  Burnett and Drossman (2005) 
suggest that increased abnormal muscle contractions, spasms, cramping, and pain 
can increase psychological distress through cognitive interpretation.  Therefore, 
not only does the brain affect the gut, but the activity in the gut also affects central 
pain perception, mood, and behavior. 
 Patients with functional GI disorders report greater psychological distress 
than healthy subjects or other medical patients overall (Dancey, Taghavi, & Fox, 
1998).  Psychologically distressed individuals may engage in health behaviors 
(i.e., drinking alcohol, smoking, caffeine, poor eating habits) that negatively 
influence the GI tract.  Thus, psychological and behavioral responses (coping 
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style) may influence neurological responses, the GI tract, and, consequently, IBS 
related symptom severity.  Although the relationship between mood and 
behaviors have been examined in individuals who suffer from IBS, the 
investigation of psychological outcomes, including distress and coping is new to 
gastroenterological research. 
Until recently, the literature has focused on differentiating patients with 
IBS from patients with irritable bowel disease (IBD) and healthy controls in order 
to find psychosocial risk factors or psychopathology as factors uniquely 
associated with IBS.  However, we believe it is important to understand why 
some persons who seek medical treatment for their IBS symptomatology are 
psychologically distressed and others are not, so alternate and more effective 
psychological interventions may be developed.  The present study utilized 
Lazarus and Folkman’s model of stress (1984, 1991) to examine the relationship 
between IBS related symptom severity and psychological health in a clinical IBS 
population.  This knowledge may contribute to future clinical interventions to 
reduce psychological distress in IBS patients seeking medical treatment.  To our 
knowledge, no studies have examined IBS related symptom severity, coping style, 
and psychological health in a clinical population on antispasmodic medication.   
 The focus of this study was to determine whether coping style moderated 
the relationship between IBS symptom severity and psychological distress in a 
clinical IBS population.  First, we sought to study the relationship between IBS 
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specific stressors and psychological distress (anxious &depressive 
symptomatology), while controlling for general perceived life stressors.  Second, 
the moderating role of active and avoidant coping, IBS specific stressors, and 
psychological distress was explored.   
 The following IBS literature review will examine the unique features of 
IBS in the context of GI disorders.  This is then followed by a review of current 
treatment procedures for IBS and research trends in the gastroenterological field.  
First, IBS is defined, classified, and historically explored.  Second, stress is 
defined and stressors related to IBS are presented.  The literature review then 
features research on distress and its role in IBS related symptom severity, 
pathophysiology, behavioral pathways, and treatment interventions.  Third, an 
examination of the relationship between distress and its role in IBS related 
symptom severity is reviewed, followed by support for the coping framework.   
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      CHAPTER 2: IRRITABLE BOWEL SYNDROME 
 
2.1 Description 
 Irritable bowel syndrome, most know in the community as “IBS,” is the 
most prevalent, costly, and disabling of the 25 functional gastrointestinal (GI) 
disorders (Hahn, Yan, & Strassels, 1999).  IBS is identified by a variety of other 
terms such as: spastic colon, spastic colitis, mucus colitis, and nervous or 
functional bowel (Yamada, 2000).  IBS is characterized by a cluster of 
symptoms including abdominal pain or discomfort associated with altered 
bowel habits (e.g., diarrhea, constipation) in the absence of organic disease 
(Hassler, 2003; Lackner & Blanchard, 2005).  In addition, because the locus of 
the disorder is in the function of the colon, frequently referred to as the “gut” by 
gastroenterologists, and not abnormalities in its physical structure, IBS is 
categorized as a functional disorder (Latimer, 1983). 
The “gut” or colon, representing the last five feet of the intestine, serves 
two functions in the body.  First, it dehydrates and stores stool so that, normally, 
a well-formed soft stool occurs.  Second, it quietly propels the stool from the 
right side over to the rectum, storing it there until it can be evacuated.  This 
movement occurs by rhythmic contractions of the colon (Manning, 1978; 
Hasler, 2003). 
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When IBS occurs, the “gut” does not contract normally.  Instead, it 
seems to contract in a disorganized, and at times violent, manner.  The 
contractions may be terribly exaggerated and sustained, lasting for prolonged 
periods (e.g., hours, days, even months).  These abnormal contractions result in 
changing bowel patterns with constipation being most common (Latimer, 1983).  
However, diarrhea, pain, and discomfort are also factors associated with IBS 
(Hasler, 2003).  
A second major feature of IBS is abdominal discomfort or pain.  Pain 
may move around the abdomen rather than remain localized in a specific area.  
Disorganized, painful contractions often lead to a pattern of altered bowel 
movements.  Diarrhea may occur, especially after meals, as the entire gut 
contracts and moves liquid stool quickly into the rectum, or localized areas of 
the colon may remain contracted for a prolonged period (Blanchard, 2001; 
Hasler, 2003).  When this occurs, the stool may be retained for a prolonged 
period of time, become hard, and become difficult to pass (Blanchard, 2001).  
Air may also accumulate behind these localized contractions, causing the bowel 
to swell, leading to bloating and abdominal distress.  The cause of most IBS 
symptoms such as diarrhea, constipation, bloating, and abnormal pain, are due 
to this abnormal physiology of the gut (Manning, 1978; Hasler, 2003). 
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2.2 Patient Profiles on Characteristics and Predictors of IBS 
 The aim of this review is to provide greater insight into the prevalence 
and role of psychosocial factors in the pathogenesis of IBS.  Although the exact 
pathophysiology of IBS remains evolutional, age, gender, physical, sexual abuse 
history, and psychological distress (depression & anxiety) have been related to 
IBS. 
2.2.1 Incidence and Prevalence 
 IBS is the most prevalent digestive disease, accounting for 12% of visits 
to primary care physicians and 28% of referrals to gastroenterologists (Mitchell 
& Drossman, 1987; Harvey, Salih, & Read, 2000).  The precise incidence or 
prevalence of IBS is uncertain, but based on Rome II criteria (see Appendix B); 
an estimated 30-60 million American adults suffer from IBS at any one time 
with approximately a 1-2% incidence rate per year (Dancey, Taghavi, & Fox, 
1998; Drossman, Sandler, McKee & Lovitz, 1982).  These incidence and 
prevalence rates of IBS syndrome are relatively consistent around the Western 
world (Thompson, 1999).   
 Mitchell and Drossman (1987) surveyed a sample that consisted of 20% 
of American Gastroenterological Association practices (N=1,000) with a 70% 
rate of return.  This large group of American GI specialists identified 41% (410) 
of their patients as having a functional GI disorder.  Of those, 68% (280) 
patients were identified as having IBS.  Thus, IBS is common in the practices of 
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GI specialists and accounts for 20-30% of new-patient visits to 
gastroenterologists each year (Hahn et al., 1999).  In addition, a population-
based community sample conducted in Olmstead County surveyed 835 eligible 
subjects with an 82% response rate.  The definition of IBS using the thresholds 
of two, three, and four or more of the six Manning symptoms (see Appendix A) 
for age-adjusted prevalence, estimates were 17%, 12%, and 9% respectively 
(Talley et al., 1991).  
2.2.2 Age 
 IBS is a condition that usually begins in young people under the age of 45, 
and often in their teens or early 20’s (Hahn et al., 1999).  In a community-based 
study by Hayams et al. (1996), IBS symptoms were reported by 6% of middle 
school students and 16% of high school students.  Although most people who 
seek treatment are in their 30s and 40s, many studies have not reported age at 
presenting symptoms or, perhaps more important, age at onset.  This suggests 
rates of IBS in young people may be under reported. 
 The symptoms of IBS may wax and wane, being particularly severe at 
some times and absent at others.  IBS is extremely common and present in about 
half of patients evaluated by gastroenterology specialists (Drossman, Toner, 
Diamant, Creed, Thompson, Read, Babbs, Barreiro, Bank, Whitehead, Schuster, 
& Gutherie, 1995).  IBS tends to run in families, and is neither life threatening nor 
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associated with the development of GI diseases such as cancer (Heitkemper et al., 
2001).   
2.2.3 Gender 
 In Western countries, women often report IBS more, whereas in Eastern 
countries men more often report IBS more frequently (Dancey, Hutton-Young, 
Moye, & Devins, 2002).  Most researchers tend to attribute this difference to 
psychosocial factors associated with illness behavior, since women are more 
likely to seek medical care in the West as compared to the East.  Women 
comprise approximately 75% of reported IBS sufferers in the United States 
(Heitkemper & Jarrett, 2001), although this gender predominance is not 
worldwide.  In recent studies from Australia (Chang & Heikemper, 2002), Great 
Brittain (Heaton et al., 1992), Bangladesh (Masud et al., 2001), India, & Sri 
Lanka (Mendis et al., 1986) female gender is not a factor in determining health 
seeking behavior for IBS symptomatology.  Shaw et al. (1997) concluded that 
when disparity between genders is found this may be due primarily to 
sociocultural role stress, which may shift as more women become exposed to 
the professional and social stresses to which men have traditionally been 
accustomed.  Furthermore, Lu et al. (2005) noted treatment seeking for IBS may 
include many variables which require attention, such as sociocultural, genetic, 
environmental, life style, behavioral, and psychological components.  Therefore, 
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gender, in its own right, has not been identified as a predictor of IBS in either 
Western or Eastern Countries. 
2.2.4 Abuse History
 While it is beyond the scope of the current research to discuss the various 
issues related to the identification of IBS as a “woman’s disease,” it does appear 
to afflict more women than men, and certainly is the most common of GI 
disorders that cause women to seek medical treatment (Meisler, 2001).  As noted 
above, although not worldwide, women comprise approximately three-fourths of 
reported IBS sufferers in Western Countires (Heitkemper & Jarrett, 2001).  The 
presence of current or past physical and sexual abuse in the histories of IBS 
patients persists and the assumption is that the relationship between abuse and 
later development of functional bowel disorders generally has been accepted in 
the research community.   
 Hobbis, Turpin, and Read (2002) point out studies on which this 
association is based are flawed by small samples, ambiguous definitions of abuse, 
and lack of proper control subjects.  In addition, Drossman et al. (2000) report 
that 53% of functional GI patients acknowledge a history of sexual abuse, as 
compared to 37% of GI patients with organic diagnoses.  However, of note, the 
majority of patients with IBS do not report abuse, and the majority of women who 
report abuse do not have IBS.  Although an abuse history tends to produce a 
poorer health outcome, the mechanisms by which abuse contribute to the 
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development of IBS have not yet been elucidated (Drossman et al., 1995; 1996).  
These effects on outcome may be mediated through the CNS pathways that 
amplify the pain experience or the patient’s perceived ability to cope with it 
(Drossman et al., 1997).  As more evidence accumulates, the incidence of abuse 
in the general population is higher than previously thought.  Therefore, the current 
data to support the high prevalence of abuse among IBS patients becomes 
questionable.   
The study conducted by Hobbis et al. (2002) was designed to reevaluate 
the relationship of previous abuse to the incidence of IBS.  Healthy individuals 
were included as the control group, along with chronic idiopathic constipation 
(CIC) patients, and patients with Crohn’s disease, in an attempt to isolate the data 
on IBS patients from that collected about patients with other chronic bowel 
diseases.  The participants completed an abuse questionnaire, a 12-item general 
health questionnaire, the extensive SCL-90 (a psychiatric symptom measure), and 
a brief bowel disease questionnaire.  They also participated in a semi-structured 
interview on a broad range of topics, including their abuse experience.  After 
careful data analysis, the researchers found prevalence of abuse experience was 
not significantly different among the four participant groups.  Thus, we conclude 
there is no clearly defined relationship between IBS and physical and/or sexual 
abuse.   
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In addition, Blanchard (2001) thoroughly reviewed existing studies of the 
possible link between early abuse and IBS, including his own extensive work, and 
was unable to reach a firm conclusion.  Instead, he offers a conceptual model to 
demonstrate possible pathways between early abuse and adult IBS.  The primary 
difficulty is sorting out other potential effects of early abuse, particularly the 
psychological effects, from biophysical effects that may lead later in life to GI 
symptoms, illness behavior, and treatment seeking (Blanchard, 2001).  
Blanchard’s model suggests that there is an underlying predisposition to develop 
GI symptoms especially when stress occurs.  Early physical and/or psychological 
abuse may create arousal and psychological distress.  Blanchard (2001) believes 
that this may lead to an increase in symptom reporting combined with 
reinforcement of illness behavior.  This may lead one to seek treatment for IBS 
and they are then termed an “IBS patient”.  
Although current research suggests those who have experienced abuse 
may report higher incidences of IBS, the correlation between the two is extremely 
unclear due to ambiguous definitions of abuse, lack of proper control subjects, 
and small sample sizes.  Therefore, no direct cause and effect has been found 
between abuse and IBS.  For these reasons, it is necessary to have a clear 
definition of constructs when investigating the relationship between IBS symptom 
severity and psychological health in the clinical IBS population.    
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For the purpose of this study, examination of potential differences in age 
and gender were explored through comparisons.  However, physical and sexual 
abuse history, as they pertain to IBS specific stressors and psychological distress, 
was beyond the scope of the current study.   
Summary
 Researchers agree that psychosocial factors play a contributing role in 
IBS.  However, disagreement exists as to which psychosocial factors (age, 
gender, abuse history, psychological states) play into the development and 
exacerbation of IBS.  Many studies conducted to date on IBS have used 
retrospective data, invalidated measures, poor control groups, small sample 
sizes and/or ambiguous definitions of constructs.  Therefore, this creates a call 
for further reliable and valid research investigating the contribution of 
psychosocial factors, such as coping, to account for the psychological distress 
associated with IBS. 
2.3 Diagnosis of Irritable Bowel Syndrome 
Because no clear diagnostic markers exist for IBS, all definitions are based 
on the Rome II criteria (see Appendix B) for diagnosis.  These criteria include at 
least 3 months of continuous or recurrent abdominal pain or discomfort that has 
two of the following features: relief by defecation, association with a change in 
the frequency, and a change in stool form (Olden, 2002).  
 
Page 14 of 153  
Coping and Irritable Bowel Syndrome 
  Historically, gastroenterology specialists have had difficulty defining 
IBS over the past several decades.  However, two diagnostic features have 
remained consistent throughout.  First, IBS is a diagnosis of exclusion; that is, 
only after all organic GI diseases are ruled out, can a diagnosis of IBS be 
determined.  Second, no definitions of IBS rely on a definitive test, in part due 
to the chronic and intermittent symptoms.  Thus, diagnostic criteria are based on 
self-report of symptoms and established patient symptom profiles (Goldberg & 
Davison, 1997).  This is problematic in the treatment of IBS because scientists 
have not discovered a root cause.  Therefore, treatment is often difficult. 
Originally, a diagnosis of IBS was determined according to clinical 
criteria that included recurrent abdominal pain or extreme tenderness 
accompanied by disordered bowel habits (Latimer, 1983).  This form of 
diagnosis is limited due to a diagnosis of exclusion rather than one that relies on 
organic criteria.  Second, as researchers and physicians began to understand the 
clinical presentation of the IBS patient, several other symptoms were involved 
such as bloating, flatulence, belching, and noticeable bowel sounds, as reported 
by the gastroenterology physicians through their clinical observations and 
patient reports (Latimer, 1983). 
2.3.1 Manning Criteria 
 In the late 1970’s, Manning et al. (1978) attempted to redefine the 
clinical criteria for IBS (see Appendix A).  Through a few years of research, 
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Manning et al. (1978) developed criteria to differentiate IBS from organic 
disease: looser stools at onset of pain, more frequent bowel movements at onset 
of pain, pain that decreased after a bowel movement, and visible bloating.  After 
conducting in-depth studies to evaluate if these criteria helped to differentiate 
IBS from organic disease, gastroenterologists still had a 24% margin of error 
(Talley et al., 1986).  This continuous misdiagnosis (or lack of diagnosis) leads 
24% of IBS patients to continue to seek treatment, and questioning the etiology 
of their physical symptoms.  Therefore, reevaluation of diagnostic markers of 
IBS is considered necessary. 
2.3.2 Rome Criteria 
 In the late 1980’s, the international gastroenterology community 
attempted again to redefine the criteria for IBS.  Drossman, Thompson et al. 
(1990) produced the first published report proposing the Rome criteria, after the 
13th International Congress of Gastroenterology held in 1988 (see Appendix B).  
One of the main criticisms that the gastroenterology community had about the 
definition of the Rome criteria is the lack of such symptoms as urgency, 
abdominal pain, or diarrhea.  Another concern was the Rome criteria’s 
requirements of both abdominal pain and chronic alteration of bowel habits 
were too strict for the diagnosis (Drossman et. al., 1990). 
 Recently, a revised version of the Rome Criteria, known as Rome II, was 
published making this criterion less restrictive (Thompson et al., 1999).  The 
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Rome Criteria II has the addition of a requirement stating that two out of three 
pain-related symptoms ensure that altered bowel habits are always present (see 
Appendix C).  As more research on the etiology of IBS continues, revisions of 
the diagnosis requirements are necessary.   
Summary 
 Although IBS continues to be a diagnosis by exclusion, the Rome II 
criteria includes the most comprehensive points to diagnose IBS to date, making a 
positive diagnosis of IBS more valid.  The Rome II criteria is more 
comprehensive, today gastrointentionalists continue to recommend a general 
physical exam, sigmoidoscopy, endoscopy or colonoscopy, a complete blood 
count, and stool sample to rule out possible alternate medical or GI disorders prior 
to an IBS diagnosis (Blanchard, 2001). 
2.4 IBS and Functional Disorders 
Functional gastrointestinal (GI) disorders can affect any part of the GI 
tract, including the esophagus, stomach, and intestines.  As noted previously, 
these disorders are classed as “functional” because they are not thought to be 
explained by underlying structural or biochemical abnormalities, as opposed 
to organic disorders, which can usually be attributed to a specific 
physiological etiology (Thompson et al., 1999).  As a result, x-rays, blood 
tests, and endoscopies can have essentially normal results and pharmaceutical 
treatments and corrective surgery tend to have limited success.  For these 
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reasons, direct treatment of functional disorders is often difficult for 
physicians to, which may lead to an increase in distress in IBS, suffers (Lynn 
& Friedman, 1993; Horwitz, & Fisher, 2001).  Functional disorders, such as 
IBS, are increasingly linked to psychosocial factors, such as psychological 
states, level of severe life events, sexual or physical abuse, and/or 
psychological traits (Drossman, 2003).  However, with IBS, psychological 
variables such as maladaptive coping styles have not clearly been elucidated. 
2.5 Current Treatments for IBS
Today, no universally accepted medical option for the full range of 
symptoms of IBS is available.  No single medication (or class of medications) 
has found to be consistently superior to placebo treatments in well-designed 
clinical trials.  Therefore, IBS suffers are left having to manage the “trial and 
error” approach to treating their IBS related symptoms supporting the 
exploration of coping style as it relates to IBS. 
2.5.1 Medical Treatment 
 When gastroenterologists first diagnose a patient with IBS, some begin 
with a conservative treatment depending on the frequency and level of physical 
symptomatology.  A common conservative treatment for IBS is the addition of 
fiber to the diet, which expands in the “gut” reducing the likelihood of a spasm 
during digestion.  Research has found that fiber promotes regular bowel 
movements, which helps to reduce constipation.  Gastroenterologists may also 
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recommend a food diary, which may help to identify any food allergies that may 
be present and help to avoid foods known to increase symptoms of IBS (Yamada, 
Alpers, Kaplowitz, Laine, Owyang, & Powell, 2003). 
  2.5.2 Medications
 When a first line dietary approach does not appear to relieve IBS related 
symptomatology, Gastroenterologists may seek a more aggressive approach 
with antispasmodic medications, such as dicyclomine and hyoscyamine 
(Yamada et al., 2002).  Antispasmodic medications assist in slowing 
contractions of the digestive tract reducing the chance of spasms (Hassler & 
Owyang, 2003).  Unfortunately, antispasmodic medications have the chance of 
experiencing side effects such as lethargy and thus are not appropriate for 
everyone.  The following newer medications are typically reserved for persons 
with symptoms that do not improve with the above stated treatments: Tegaserod 
(Zelnorm) are used in the short-term treatment of women with constipation-
dominant IBS.  Tegaserod stimulates the digestive tract to maintain movement, 
decreasing the risk of developing constipation.  The safety and efficacy of 
Tegaserod has not been sufficiently studied in men.  Therefore, the US Food 
and Drug Administration (FDA) neither approved the drug for long-term 
treatment in women nor the treatment of IBS in men (Hassler &Owyang, 2003).  
Alosetron (Lotronex) is only approved for short-term treatment of women with 
severe, chronic, diarrhea-predominant IBS who have failed to respond to 
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conventional IBS therapy.  Fewer than 5% of people with IBS have the severe 
form, and only a fraction of people with severe IBS has the diarrhea-
predominant type (Yamada et al., 2002).   
2.5.3 Psychosocial Treatments of IBS 
Between the years of 1982 and 2003, protocols designed to assess the 
psychosocial treatment of IBS have dramatically increased (Hassler, 2003).  
Some of the most promising outcome data stems from clinical trials testing 
psychological treatments.  Brief psychodynamic psychotherapy with relaxation, 
hypnotherapy, cognitive therapy, and cognitive behavioral therapy have been 
shown to be more effective than symptom monitoring or routine medical care in 
reducing IBS symptoms (Lea & Whorwell, 2000; Lackner, Mesmer, Morley, 
Dowzer, & Hamilton, 2004).  As noted, with the focus on outcomes, treatment 
studies have received significant attention in recent years among academics and 
practitioners.   
 Cognitive behavioral therapy involves both education and behavioral 
conditioning by challenging distorted or irrational thinking, which leads to 
psychological distress.  Through a cognitive behavioral intervention, Payne-
Blanchard (1995) found improvement in reducing GI symptoms in the cognitive 
therapy group as compared to a self-help group and wait list control.  At the 
three-month follow-up, the patients had maintained both the improvements in 
their symptoms and in their perception of overall well-being. 
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However, to date, the most effective and empirically supported 
psychological treatment found to reduce distress in IBS patients was developed 
by Blanchard et al. (2001) termed cognitive therapy for IBS patients.  The 
understanding of the bi-directional neural pathways of the Brain-Gut Axis and 
the higher order brain processes, such as attention and thoughts, have the 
capacity to alter GI function by modifying the signals between the brain and 
gut, is the basis of this cognitive therapy model of treatment (DePonti & 
Malagelada, 1998).  Therefore, the goal of the cognitive therapy implemented 
by Blanchard et al. (2001) is to teach patients a set of information-processing 
and problem-solving skills to reconfigure the “faulty wiring” between the gut 
(ENS) and brain (CNS).  Cognitive interventions, by Blanchard et al. (2001), 
consisted of (a) increasing patient’s awareness of the relationship between 
stressors, thoughts, and IBS related symptoms, (b) training patients to identify 
and modify their cognitive appraisals of situations, thoughts, and behaviors, and 
(c) changing underlying depressive cognitions. 
Other treatment approaches, such as complementary and alternative 
therapy, report to achieve some success in reducing physical and psychological 
symptoms of IBS.  These treatment approaches include, but are not limited to, 
hypnosis (Whorwell, Prior, & Faragher, 1984; Prior, Colgan, & Whorwell, 
1990; Houghton, Heyman, & Whorwell, 1996), reflexology (Tovey, 2002), brief 
psychotherapy (Svedlund, Sjodin, Ottosson, & Dotevall, 1983; Guthrie, Creed, 
 
Page 21 of 153  
Coping and Irritable Bowel Syndrome 
Dawson, & Tomenson, 1991), and body awareness therapy (Eriksson, 
Nordwall, & Kurlberg, 2002). 
2.6 Pathophysiology of IBS 
 Today, IBS research examines the importance of the “The Brain-Gut 
Axis,” or the relationship between the gut (upper & lower GI tract), brain, and 
central nervous system (CNS) (Mayer et al., 2002).  Presently, the pathogenesis of 
IBS is poorly understood.  However, roles for abnormal gut motor and sensory 
activity, central neural dysfunction, psychological disturbances, stress, and 
luminal factors have been proposed.  Recent studies have lead to a greater 
understanding between the brain and the gut (enteric nervous system).  Currently, 
the model for IBS incorporates enhanced motility, abnormal sensation, and 
autonomic reactivity modulated by the central nervous system (CNS) - (ENS) 
interaction. 
 IBS is recognized as a biopsychosocial disease in which several major 
mechanisms interact, including enhanced visceral (pertaining to all smooth 
muscle & glands throughout the body) sensation, central perception of visceral 
events, abnormal intestinal motility, and abnormal psychological factors (Garnett, 
1999; Quigley, 2003).   
2.6.1 Deregulation of the Nervous System  
 Five different classes of neurons innervate the GI tract: intrinsic, vagal 
afferent, spinal afferent, parasympathetic efferent and sympathetic efferent 
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(Holzer et al., 2001).  Each aspect of digestive activity is under regulatory 
influence of neurons, among which the ENS has the most important role (Holzer 
et al., 2001; Kirkup et al., 2001). 
 The Brain-Gut Axis bi-directional pathway plays a prominent role in 
modulation of gut function.  Signals from sensory sources to the brain (e.g., 
sound, sight, smell, visceral, & somatic sensations) play a role in reflex regulation 
and modulation of mood states (Drossman et al., 2002; Burnett & Drossman, 
2005).  Sensory inputs modified by memory, cognition, and affect, and integrated 
with neural connections in the CNS, spinal cord, autonomic nervous system 
(ANS), and ENS (Drossman et al., 2002; Garnett, 1999; Kirkup et al., 2001; 
Burnett & Drossman, 2005).  Sensory inputs can have physiologic effects on the 
GI tract, such as motility, secretion, immune function, and blood flow (Drossman 
et al., 2002; Garnett, 1999).  Furthermore, this miscommunication between the 
CNS and ENS creates abnormal muscle contractions or spasms, which frequently 
leads to cramping, pain and discomfort often reported by clinical IBS patients 
(Blanchard, 2001; Bloomhoff, 2001). 
 The activation of the Brain-Gut Axis is dependent on peripheral and 
central events and individual experiences (Drossman et al., 2002).  IBS specific 
stressors and distress (anxious & depressive symptomatology) can enhance the 
perception of painful events, whereas distraction, relaxation, hypnosis, and 
cognitive therapy can decrease perceptual sensitivity (Drossman et al., 2002).   
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2.6.2 The Brain-Gut Axis  
 Substantial data now supports the concept of an enhanced responsiveness 
of central stress circuits and associated altercations in neuroimmune interactions 
to external (e.g., psychosocial factors) or internal (inflammation) stressors as part 
of the underlying pathogenesis of IBS (Mayer et al., 2001).  As noted earlier, such 
stress hyper-responsiveness results in altered autonomic neuroendocrine outputs, 
as well as, alterations in endogenous pain modulation (Bloomhoff et al., 2001). 
 The underlying pathogenesis of IBS is one with altercations in the brain-
gut interaction, visceral perception, autonomic and enteric nervous system 
function, and can result in pain, altered bowel habits, and other symptoms.  
                                
 
  Figure 1.  A diagram of The Brain-Gut Axis (Mayer et al., 2002)   
 
Page 24 of 153  
Coping and Irritable Bowel Syndrome 
 In healthy (non-IBS) individuals, distension of the gut will activate nerve 
fibers lining the gut that transmit signals to higher centers in the brain, which 
register pain.  In persons seeking treatment for IBS, it has been shown pain can be 
perceived at much lower levels of distension, known as 'hypersensitive gut' or in 
scientific terms, visceral hyperalgesia (Mayer et al., 2002).  It follows that 
abnormal motility will lead to areas of distension that will react because of the 
“hypersensitive gut” and register the sensation of pain in the higher centers of the 
brain (Mayer et al., 2002).  Burnett and Drossman (2005) found the Brain-Gut 
Axis to be a bi-directional relationship, where increased atypical muscle 
contractions, spasms, cramping, and pain can amplify psychological distress 
through cognitive interpretation.  Several factors affect function of the CNS and 
show, by virtue of the connections of the Brain-Gut Axis, to affect the events 
described above in the intestines (ENS) (Bloomhoff et al., 2001). 
  One recent theory of IBS notes that hypersensitivity may be related to an 
imbalance of serotonin (5-HT), or a faulty communication network between 
serotonin in the gut, the brain, and the spinal cord (Brain-Gut Axis Dysfunction) 
(Bloomhoff, Spetalen, Jacobson, Morten, &Malt, 2001).  Approximately 95% of 
serotonin (also know as 5-HT), a naturally occurring neurotransmitter, resides in 
the GI tract (Hasler, 2003).  As a neurotransmitter in the ENS, 5-HT (serotonin) 
plays a role in initiating responses such as modulating intestinal movement, 
modulating perception of pain, and mediating secretion in the GI tract (i.e., 
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release of water, which ultimately helps to soften stools) (Garnett, 1999), helping 
the GI tract function normally.  Moreover, at the end organ level (ENS), certain 
levels of perceived stress have shown a greater adverse effect on intestinal 
motility and sensation than in non-IBS sufferers (Mayer et al., 2002).   
 The activation of the Brain-Gut Axis is therefore dependent on peripheral 
and central events as well as individual experiences.  IBS specific stressors and 
distress (namely anxious & depressive symptoms) can enhance the perception of a 
painful event (Blomhoff et al., 2001).  That if one evaluates their environment as 
stressful and uses an ineffective coping style, the activation of the Brain-Gut Axis 
may continue.  The literature is lacking in the understanding of this relationship 
and the question remains, do IBS patients evaluate and cope ineffectively with 
IBS related symptoms leading to an increase in IBS related symptoms and 
distress?  The current study plans to shed some light on these relationships.   
Summary 
No clear diagnostic markers exist for IBS.  Therefore, the base of all 
definitions is on the Rome II criteria for diagnosis (see Appendix B). 
Increasingly, IBS relates to psychosocial factors, and is the most prominent of 
the functional GI disorders (Drossman, 2003).   
A wide range of medical treatments, from increased fiber intake to 
antispasmodic medications, has increased in the realms of research and 
prescriptions by physicians.  To persons seeking “trial and error” medical 
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treatment for IBS symptomatology, this may be quite frustrating.  Recently, 
researchers have employed more treatments that are psychological in nature.  
These include, but not limited to, psychotherapy, hypnosis, relaxation therapy, 
and biofeedback (Lea & Whorwell, 2001).  To date the most empirically 
supported psychological treatment for IBS developed by Blanchard et al. 
(2001) is termed cognitive therapy for IBS patients.  The goal of this 
intervention is to teach patients a set of information-processing and problem-
solving skills to reconfigure the “faulty wiring” between the ENS and CNS.  
This cognitive therapy for IBS patients along with stress management 
techniques has shown most effective in reducing IBS related symptoms and 
psychological distress.    
Recent studies have lead to a greater understanding between the brain 
(CNS) and the gut (ENS) (Mayer et al., 2002).  Currently, the model for IBS 
incorporates enhanced motility, abnormal sensation, and autonomic reactivity 
modulated by the central nervous system (CNS) - (ENS) bi-directional 
interaction termed the Brain-Gut Axis.  Research has revealed that IBS may 
be related to an imbalance of serotonin (5-HT) in the gut, an improper reaction 
of the digestive system to serotonin, or a faulty communication network 
between serotonin in the gut, the brain, and the spinal cord (Brain-Gut Axis 
Dysfunction)(Hassler, 2003).  This activation of serotonin through the Brain-
Gut Axis is important and psychological distress an individual is experiencing 
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may be a trigger.  One’s poor coping abilities with IBS specific stressors may 
create this psychological distress.  Therefore, IBS becomes a vicious cycle 
where once the activation takes place the appraisal and coping of IBS 
symptomatology may help activate an increase in distress thorough this 
complex system.  This is an important bi-directional role of emotions, coping, 
and activation of the Brain-Gut Axis. 
    
           
 
 
 
 
 
 
 
 
 
 
 
 
        
 
Page 28 of 153  
Coping and Irritable Bowel Syndrome 
    CHAPTER 3: STRESS 
 Definitions of stress and psychological distress are inconsistent in the 
literature, making it difficult to separate the theoretical ideas of stress and 
psychological distress in the research.  Therefore, constructs utilized in this study 
are defined. 
3.1 Definition  
 Stress is defined by a quality of experience, shaped through the interaction 
of a person and environment that results in psychological or physiological 
distress.  An event is considered a stressor, when one’s evaluation of internal and 
external demands exceeds perceived coping resources resulting in distress 
(Lazarus & Folkman, 1984).  The interpretation of a specific event to be stressful 
depends on one’s cognitive appraisal.  The internal or external stimulus that is 
appraised as threatening is termed a stressor.  For the purpose of this study, IBS 
related stressors were examined.   
 It has been well established in both the psychological and medical 
community that stress is associated with negative health outcomes in almost every 
array of illness (e.g., backaches, headaches, & heart disease) (Brown & Harris, 
1989; Baum & Singer, 1987).  More specifically, stressful experiences have been 
found to be risk factors in developing functional disorders such as IBS (Dancey et 
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al., 1998).  For the purpose of this study, IBS related symptom severity and 
psychological distress will be examined.  A stressor is defined as a stimulus or 
event that is evaluated as harmful and results in a reaction.  When a stressor 
results in a response that is physiological and/or cognitive behavioral in nature it 
is regarded as distress.  For the sake of this study, distress is defined as the 
physiological (IBS related symptoms) and psychological (anxious & depressive 
symptoms) reaction within an individual.  
 Although IBS is recognized in the literature as a major health related 
stressor, many IBS studies fail to incorporate an IBS related symptom severity 
measure to evaluate the degree to which IBS related physical symptoms are 
experienced (Glise et al., 2002).  Furthermore, many studies relating to IBS 
symptom severity failed to utilize measures of psychological distress when IBS 
symptom severity was being measured (Whitehead, 1994).  Therefore, the present 
study was designed to evaluate IBS physical symptom severity, anxiety and 
depression, and control for general perceived life stressors to provide a more 
accurate portrayal of stress and distress experienced from IBS related symptoms 
in a clinical population. 
 Today, in any discussion of functional health conditions such as IBS, it is 
imperative to account for the influence of stress, a term widely used to describe a 
vast range of factors.  Most psychological researchers rely on the “stress 
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hypothesis,” which refers specifically to events and their influence on physical 
and psychological well-being.  Though there is no universal agreement by 
psychologists on the definition of stress, they do agree that stress represents an 
interaction between an individual and his or her environment (Lazarus, 1966; 
Lazarus & Folkman 1984).   
 The cognitive transactional perspective is the most widely accepted 
model of stress in the field of psychology to date and the model that this study is 
based upon.  Defined by Lazarus and Folkman (1984), stress is an individual’s 
cognitive interpretation of potentially stressful events.  The way an individual 
perceives the event is more important than the event itself.  In short, stress is 
seen as a transaction between person and environment.  The two fundamental 
processes to this transaction are appraisal and coping (Lazarus & Folkman, 
1984). 
Life 
Events 
Resources 
Appraisals Health 
Consequences 
Coping 
Social 
Support
 
      Figure 2.  Process model of the stress/ health relationship based on the   
  Transactional Stress Theory by Lazarus (1991) 
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Lazarus (1991) regards stress as an active process that is composed of 
causal antecedents, mediating processes, and effects.  Antecedents are person 
variables, such as beliefs, and environmental variables.  Mediating processes 
refers to an individual’s coping and appraisal of demands and resources.  
Experiencing stress and coping brings forth both immediate effects (e.g., 
physiological changes) and long-term effects related to psychological well-being, 
somatic health, and social functioning (see Figure 3). 
 According to Lazarus and colleagues (1991), cognitive appraisal refers to 
an individual’s assessment of his or her current situation and the resources 
available for coping with it.  This cognitive appraisal process is central to the 
degree of stress one experiences and therefore emotionally responds.  When a 
perceived threat goes beyond the resources for coping with the stressor, an 
individual will experience stress.  Assessment of potential danger is referred to 
primary appraisal, whereas the evaluation of available resources is termed 
secondary appraisal.  Primary appraisal asks the question “Am I in danger?”   
Whereas secondary appraisal asks the question, “What can I do about this?”  In 
the case of an individual suffering from IBS, primary appraisal of IBS symptoms 
may be interpreted as threatening.  Furthermore, IBS is a functional disorder with 
no definitive diagnosis or treatments.  IBS suffers frequently report feeling little 
control over their IBS symptoms.  The distinction between primary and secondary 
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appraisal is largely designed to demonstrate the basic cognitive processes 
involved (Bishop, 1994).   
 Coping is another major process and refers to a person’s efforts, both 
cognitive and behavioral, to deal with a perceived stressful situation (Manne, 
2003).  In the case of the clinical IBS patient, poor coping abilities (more 
avoidant) may lead to an increase in psychological distress.  This supports the call 
for further research of coping and its relationship between IBS related symptom 
severity and psychological distress. 
Lazarus and his colleagues (1981) view stress as a dynamic process 
involving both the individual and the situation.  The initial situation provides the 
stimulus (IBS symptoms), but how a person interprets their IBS symptoms and 
the type of coping resources employed determines the level of distress one 
experiences.  Coping depends on appraisal of the situation, but conversely, the 
results of coping are likely to alter the person’s appraisal (Bishop, 1994). 
As discussed above, there are several components of the stress response.  
First, appraisals of harm or loss posed by the stressor (IBS symptoms) are thought 
to be important determinants of coping (Lazarus, 1981).  Second, appraisal of the 
degree of controllability of the stressor (IBS symptoms) is a determinant of 
coping strategies selected.  A third component is the person’s evaluation of the 
outcome of his or her coping efforts and expectations for future success with 
coping with the stressor.  These judgments lead to changes in the types of coping 
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employed.  The assessment of stress depends on whether the emphasis lies on 
either the stimulus (the external event) or the response (the characteristics of the 
individual).  Since IBS is a disorder diagnosed by exclusion, and treatments are 
“trial and error” in nature, one may not have a favorable view of potential 
successful outcomes presently or in the future. 
3.2 Current Stress Research 
 The majority of IBS sufferers are aware there is an association between 
increased psychological distress and initial and subsequent flare-ups of IBS 
related symptoms.  However, it has been difficult to distinguish if IBS symptoms 
or psychological distress began first.  Now, the dominant theory by researchers 
suggests IBS is a primary disorder of the Brain-Gut Axis, the bidirectional 
interconnections between the brain (CNS) and gut (ENS).  
 The way one evaluates an environmental stimulus can create emotional 
and physiological responses that cause chemical imbalances in the brain that, may 
in turn, influence motility (the propelling of contents through the gut) (Thompson, 
1999).  These stress-related chemical changes may also influence the perception 
of pain signals sent to the brain from the sensory nerve endings that respond to 
events occurring in the intestines.  According to stress as defined above, situations 
and events that are evaluated as stressful often lead to an increase in 
psychological distress.  These stressors differ from general everyday stressors 
because they are unique to the experience and diagnosis of IBS.  Individuals 
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diagnosed with a functional disorder such as IBS, can be considered a major life 
stressor with physical symptomatology characterized as unpredictable, 
uncontrollable and embarrassing.  Hahn et al. (1997) examined the relationship 
between IBS symptom severity and physical and psychological well-being in a 
clinical population.  Hahn et al. (1997) found that persons with increased self-
reported IBS symptoms measured by the IBSQOL reported an increase in 
depression and anxiety (as measured by the SF-36) and quality of life.  
Furthermore, patients with mild to moderate IBS symptomatology reported 
statistically lower levels of psychological distress as compared to patients who 
endorsed severe (high) IBS symptomatology.    
 A Quality of Life Survey conducted with the anti-spasmodic over the 
counter (OTC) drug Equilon found, 45% of clinical IBS patients had been treated 
or were currently undergoing treatment for stress (Summer, 1999) and a further 
3% were considering receiving treatment for stress defined as anxiety and 
depression.  This finding warrants further research into the mechanisms that may 
contribute to psychological distress in those seeking treatment for their IBS 
symptoms.  Other studies have found that IBS sufferers tend to have a lower 
threshold for coping with stressful situations (such as IBS symptoms) and are 
more likely to react negatively to these events.  In turn, this creates an increase in 
both physiological and psychological distress associated with IBS (Burnett & 
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Drossman, 2005).  Therefore, the way one evaluates and copes with IBS related 
stressors may in turn increase anxiety and depression. 
 Similarly, the relationship between life events and GI symptoms is 
accepted and many doctors believe that these symptoms frequently occur around 
chronic life stresses.  For example, in two studies, IBS patients endorsed more 
stressful events (i.e., negative life events) than did patients with IBD (Mendeloff, 
Monk, Siegel, & Lilinfeld, 1970).  However, two other studies, one using the Life 
Events and Difficulties (LED) Interview (Ford et al., 1987), and one using the 
Social Readjustment Rating Scale (SRRS), showed no significant differences 
between IBS and IBD patients (Schwarz et al., 1993).  When IBS patients are 
compared with healthy controls, IBS patients report more stressful events or 
higher stress ratings (Blanchard, 2001).  Recently, studies of stress have focused 
on minor events, termed hassles, but little conclusive evidence reveals that IBS 
patients experience more minor stresses or experience them more intensely than 
non-IBS patients.  However, IBS related stress might increase their distress 
relative to other medical populations. 
 A diagnosis of IBS and the lack of treatment knowledge create an 
ambiguous, emotional, time-consuming, and potentially financially taxing 
experience.  The treatment and diagnosis of IBS includes embarrassing questions 
about daily bowel habits, blood essays, endoscopies, and symptom monitoring.  
The uncertainty and unpredictability of an onset of IBS can disrupt many daily 
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personal and social decisions.  Patients with IBS visit primary care physicians 
three times as often for non-gastrointestinal problems as do healthy persons and 
undergo more appendectomies and hysterectomies (Drossman et al., 1988).  IBS 
patients report chronic pelvic pain more.  Genitourinary dysfunction, including 
dysmenorreah, dyspareunia, impotence, urinary frequency, nocturia, and sensation 
of incomplete bladder emptying is prevalent.  Impaired sexual functioning is 
reported by 83% of IBS patients as compared to 30% of IBD patients and 16% of 
peptic ulcer disease patients (Guthrie et al., 1987).  These data suggest there is 
significant physiological and psychological distress associated with IBS. 
 Furthermore, deciding whether to socialize with friends and family, going 
to work, deciding to be intimate with a partner, and taking time off from work for 
doctor visits all become difficult decisions and may be appraised as stressful 
leading to distress.  Thus, significant disruptions of professional, social, and 
intimate relationships are very apparent in the literature.  Therefore, the way an 
individual copes with IBS specific stressors becomes a pivotal question as coping 
is likely to influence the relationship between IBS related symptoms and 
psychological distress.  Thus, the literature suggests it may not be overall life 
stress that drives one to seek treatment for their IBS related symptoms, but the 
manner in which one interprets and ineffectively copes with their IBS related 
symptoms that can lead to an increase in levels of psychological distress. 
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      CHAPTER 4: PSYCHOLOGICAL DISTRESS    
 
 Distress as it relates to the experience of IBS related symptom severity and 
coping is relevant in the investigation of a clinical IBS population.  However, the 
literature is in disagreement with definitions of distress and its impact on IBS 
related symptom severity.  Therefore, definitions utilized in this study are 
clarified.  
4.1 Definition
 Stressors associated with IBS are believed to psychologically influence the 
individual, and affect the persons they surround.  The majority of previous IBS 
literature attempts to distinguish the psychological distress levels found in clinical 
IBS patients from other organic GI disorders or the healthy population.  However, 
research that is more recent is focusing on the psychosocial consequences of IBS.  
This section strives to describe some predictors and consequences of distress 
(both psychological & physical) in the clinical IBS population, as well as some 
inconsistencies in the literature.  This will lead to the present hypothesis that 
coping moderates the relationship between IBS related symptom severity and 
distress.  For the sake of this study, distress will include physiological (i.e., IBS 
symptoms) and psychological (i.e., anxiety & depression) reactions to stressors.  
 Prior to conducting systematic qualitative research, many clinicians 
believed that IBS was “All in your head.”  While the etiology of IBS is not well 
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understood, a substantial amount of qualitative literature portraying IBS as a 
psychosomatic disorder exists.  Some researchers imply that IBS patients are 
worried focusing strictly on their IBS related symptoms (Latimer, 1983).  
However, as the development of IBS criteria became more specific and research 
increasingly reliable and valid, the associations between IBS and psychological 
distress were further associated.  Today, researchers continue to relate IBS related 
symptoms to anxiety and depression (Whitehead, 1999). 
 IBS patients are noted to have a high frequency of psychological distress, 
while IBS non-patients who do not consult a physician, appear to be 
psychologically similar to healthy controls (Harraf, Saba, Niazi, Fass, & 
Munakata, 1998).  Furthermore, despite equally severe physical symptoms, high 
levels of psychopathology are not found in other GI disorders such as 
inflammatory bowel disease (IBD), which is organic in nature (Hassler, 2003).  
While psychological symptoms are not characteristic of all individuals with 
physical symptoms of IBS, psychological distress occurs more frequently in those 
individuals who seek treatment (Whitehead, 1992).  This may be in part due to the 
type of coping style utilized to address IBS related symptoms in individuals who 
seek treatment for IBS. 
 As discussed earlier, psychological or emotional factors can disrupt GI 
function even in normal, healthy individuals, leading to symptoms such as pain 
and diarrhea (Whitehead, 1999).  Common expressions such as “butterflies in the 
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stomach” or “stomach in knots” describe the types of sensations experienced 
during a stressful situation.  These GI symptoms are reported as increasing 
distress in usually “healthy” individuals.  Stress defined as a transaction between 
person and environment affects different people in different ways.  Within an 
individual the response of the GI tract may vary daily according to one’s 
cognitive appraisal and coping resources for their current experiences and GI 
distress.  Therefore, the stress associated with IBS can lead to anxiety and 
depressive symptomatology. 
 As mentioned above, the latest theory of IBS suggests the pathogenesis of 
IBS involves abnormal brain-gut interactions, characterized by hyper 
responsiveness and/or hypersensivity in the gut (Elsenbruch, Lovallo, & Orr, 
2001).  However, it remains unclear whether this occurs at the level of the gut 
(ANS), or the CNS (brain) (Hasler, 2003).  There is evidence to support the 
importance of both visceral stimuli (e.g., colonic distension) and non-visceral 
stimuli (e.g., psychological stressors) (Elsenbruch et al., 2001).  Therefore, it is 
possible that IBS pathophysiology involves abnormal afferent (ascending) and/or 
efferent (descending) mechanisms.  Due to this bidirectional connection, the role 
of psychological and emotional factors in autonomic dysfunction, which 
previously found in response to various stimuli in patients with IBS, calls for 
further investigation (Hazlett-Stevens, Craske, Mayer, Chang, & Naliboff, 2003).   
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4.2 Psychopathology, Distress, and IBS      
 In a review of the literature published in the last 20 years, the “chicken-
and-egg” dilemma echoes with regard to the psychological dimensions of IBS.  
Blanchard and colleagues (1987) found that patients with IBS who sought 
treatment were significantly more depressed and anxious, as measured by the 
Hamilton Scales (1960), than either IBD patients or healthy controls who did not 
differ from each other.  This may be explained by a physician’s ability to define 
and treat an organic cause to IBD as compared to those with IBS (functional 
disorder) where there is no known etiology or definitive effective treatment. 
Shaw, Davies, & Dickerson (1997) concluded that psychiatric disturbances were 
the likely cause of GI symptoms, rather than a result of them.  In contrast, as 
suggested in this study, Blanchard (2001) observed that the physical and 
psychological effects of IBS appear to interact dynamically in a fashion 
apparently unique to each individual who lives with IBS.  For example, Shaw et 
al. (1999) believes that empirical work on IBS strongly supports the idea that the 
decision to seek medical care is influenced more by the psychological and social 
effects, rather than by the physical symptoms of IBS and their severity.  This 
suggests that the interpretation and coping of IBS related symptoms may lead to 
both increased physical and psychological distress.   
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4.2.1 Albany Studies 
 The Albany studies are comprised of a series of 10+ studies conducted by 
Blanchard et al. (2002) that have been conducted over the past 15 years.  Most of 
the studies are a compilation of doctoral and master’s theses supervised by Dr. 
Blanchard.  All studies were performed using the same setting, dependent 
variables, and similar diagnostic and selection procedures for the participants, 
allowing for cross-study comparisons.  The individual psychological test norms 
from the Albany Studies make it clear that some IBS patients are well within the 
normal range on many standard measures of psychological distress.  Similarly, the 
Olmstead County studies (Talley et al. 1991) demonstrate that as high as 40% of 
individuals who meet the symptomatic criteria for IBS never seek treatment for 
their GI symptoms (Drossman et al., 1993).  This suggests there is a third variable 
such as coping style that may play an integral role in IBS patients who seek 
treatment. 
4.3 IBS Related Symptoms and Distress 
 
 To our knowledge no studies examine the relationship between IBS 
related symptom severity, psychological distress, and coping in a clinical IBS 
population on an antispasmodic medication.  However, two qualitative studies 
examining the IBS patients’ perspective on their IBS experience have been 
performed.  Bertram et al. (2001) conducted a qualitative study of IBS patients’ 
perspective on IBS.  They sampled 51 volunteers (43 women & 8 men) with an 
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average age of 30.4 years.  IBS patients described their IBS illness as episodic and 
negatively affecting their daily routine.  IBS patients felt their interaction with the 
medical community neither clarified their understanding of IBS nor improved 
management of IBS related symptoms.  Bertram et al (2001) found four major 
stresses from IBS: symptoms, episodes, changes in lifestyle, and frustration.  
Abdominal cramping and diarrhea caused most individuals to see a physician and 
often triggered fear of a serious disease, especially cancer.  IBS patients described 
abdominal pain as extreme and unusual, and diarrhea as urgent and 
uncontrollable.  The sense of urgency that accompanied bouts of diarrhea and the 
inability to plan the day without taking into consideration need for proximity to a 
bathroom often was noted as frustrating.  Bloating and constipation also occurred, 
but was considered less disruptive (Bertram, 2001). 
 Due to the episodic nature of IBS, anticipation of the next episode affects 
persons in between each episode.  IBS patients noted stressors to be the common, 
but unpredictable trigger of IBS related symptom episodes in which they had little 
or no control over, suggesting appraisal and coping may play a role in this 
reaction.  The variable response of the GI tract to potential triggers was a source 
of great frustration to the participants (Bertram et al., 2001).  Most participants 
reported that they made significant changes in their work and social lives because 
of IBS.  Overall, IBS was felt to decrease work productivity and adversely affect 
the quality of work due to large amounts of time in the bathroom.  Several 
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workdays were missed (i.e., once per month), mainly because of cramping and 
diarrhea.  IBS patients universally reported strained social situations due to their 
IBS related symptoms.  Many clinical IBS patients refused social invites or social 
situations when having a bought of IBS for fear of urgency, supporting the 
connection between IBS symptom severity and increased psychological distress. 
 Furthermore, IBS patients displayed great frustration with the lack of 
control over their illness and daily lives.  The unpredictability of IBS 
exacerbations, severity of symptoms, and lack of understanding and empathy for 
their illness by family, coworkers, and physicians lead to feelings of 
disappointment, anger, and frustration.  When Dixon-Woods and Critchley (2000) 
asked clinical IBS patients how they felt about their IBS related symptoms 
responses included “It is triggered by anything, everything, and nothing.  It makes 
no sense”; “There is no control and people don’t understand that…. no one can”; 
“All of the sudden it hits you.  I am afraid sometimes to get up and move”; “I 
think that part of the stress factor is the frustration of trying to figure out what’s 
coming next.”  Most clinical IBS sufferers believe stress was the main trigger of 
their illness.  However, individuals have difficulty determining how their 
environmental and psychological stress could be minimized.  Generally, IBS 
patients showed little understanding about how to manage and cope with stress 
(Bertram et al., 2001).   
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 Due to the unpredictictability and severity of IBS related symptoms, IBS 
has been associated with an increase in psychological distress.  However, the 
literature suggests that persons suffering from IBS have negative cognitive 
distortions that lead them to believe regulating IBS symptoms is out of their 
control.  This warrants further examination of the relationships of distress, stress, 
IBS, and coping in a clinical population on an antispasmodic medication. 
Summary 
 As noted above, IBS is a stressful and debilitating functional disorder.  
Bertram et al (2001) found four major stresses from IBS: symptoms, episodes, 
changes in lifestyle, and frustration.  Abdominal cramping and diarrhea caused 
most individuals to see a physician and often triggered fear of a serious disease, 
especially cancer.  Stress is seen as an interaction between person and 
environment.  The two fundamental processes to this transaction are appraisal and 
coping (Lazarus & Folkman, 1984).  Therefore, if IBS patients feel they are 
unable to cope effectively with IBS related symptoms and utilize ineffective 
coping strategies to manage their IBS symptomatology, psychological distress 
may occur.  Examination of coping style (active & avoidant) as a moderator 
between IBS related symptom severity and psychological distress may help 
facilitate a greater understanding of stress, distress, and coping as related to IBS 
for future treatments. 
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Summary 
 Distress is a physiological and/ or cognitive behavioral response to a 
stressor.  Thus, distress involves the reaction within an individual to cope with 
external events.  Research supports the notion that changing one’s perception of 
his or her stressors through cognitive-behavioral and other treatment approaches 
reduces distress in clinical IBS patients (Payne-Blanchard, 1995).  However, the 
mechanism by which this process becomes effective remains unknown.  The 
Brain-Gut Axis hypothesis is the most recent approach to determining an answer 
to this question.  IBS related symptoms or problems related to IBS are abundant 
and should be considered when evaluating the importance of the relationship 
between IBS and distress.   
The present study argues that it is the process of coping with IBS 
stressors that are related to these health outcomes and physiological responses.  
Distress and subsequent physiological changes experienced by IBS patients, 
are a result of evaluating one’s experiences as stressful unsuccessfully coping 
with the stressor.  Therefore, the notion one’s coping style may play a key role 
in the interaction between IBS specific stressors and psychological distress 
warrants further research in this domain.    
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           CHAPTER 5: COPING 
 
 The way ones copes with IBS can directly and indirectly affect IBS related 
symptom severity outcome and psychological distress.  Individuals with poor 
coping skills may evaluate their IBS related symptoms as stressful and experience 
psychological distress as a result.  Those who ineffectively cope with their IBS 
related symptoms may do so through the use of avoidant coping strategies (e.g., 
alcohol, caffeine, or continue with poor eating habits), which may increase 
psychological distress, and exacerbate IBS symptom severity (Elsenbruch, 
Lovallo, & Orr, 2001). 
5.1 Theoretical Approaches to Coping
 Studying clinical IBS patient’s coping strategies may help to understand 
why individuals differ so greatly in their responses to IBS symptom severity and 
how these different responses are related to IBS and other heath outcomes.  
Currently there are three main theoretical approaches to coping: person-based 
approach, situational determinant approach, and the cognitive approach.  The 
person-based approach claims that personality characteristics are the primary 
cause of determining how an individual copes with stress.  The situational 
determinant approach argues the type of strategies individuals use to cope with 
situational demands depends highly on environmental demands.  In short, 
characteristics of different types of stressors call for different coping processes.   
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 The majority of coping researchers currently have adopted some aspects of 
the cognitive approach.  The cognitive approach is based on four assumptions.  
First, the way an individual copes with a problems greatly depends on their 
appraisal of the situation (Lazarus & Folkman, 1984).  Second, the cognitive 
approaches assume that individuals are flexible in their choice of coping strategies 
and modify them according to the demands of a particular event.  Third, that 
coping includes both problem-focused and emotion-focused strategies, directed at 
both the emotional and external demand.  Finally, cognitive theorists take an 
empiricist approach.  That is, to identify which coping strategies are used in a 
specific situation, and the conditions these strategies do or do not promote 
positive adaptation (Aldwin, 1999; Lazarus & Folkman, 1984).  
5.2 Definition 
  
 Lazarus and Folkman’s (1984) cognitive approach defines coping as the 
cognitive and behavioral efforts to manage with internal and external demands 
that are evaluated as challenging or exceeding one’s coping resources, which is 
likely differ among individuals, even when faced with similar stressful situations 
(Stowell et al., 2001).  These differences may be accounted by differing appraisals 
of the situation or preferences in coping style.  Evidence from research suggests 
that an individual’s preferred coping style is influenced by situational (Folkman & 
Lazarus, 1980) and dispositional factors (Carver et al., 1989).  Nevertheless, 
different coping styles may influence an individual’s ability to master, tolerate, 
 
Page 48 of 153  
Coping and Irritable Bowel Syndrome 
reduce or eliminate a source of stress such as IBS related symptoms and the 
emotional impact.  Although significant interactions of stress and coping on 
mental and physical health have been noted (Billings & Moos, 1981; Nakano, 
1991), interactions with IBS are largely unknown.  For the purposes of this study, 
Billings and Moos’ (1990) cognitive conceptualization of coping, which 
differentiates successful from unsuccessful coping (i.e., active versus avoidant 
coping), was utilized.  Active coping can include an active cognitive component, 
which results in a positive reappraisal of a situation.  Active coping as defined by 
Billings and Moos (1990) may also contain an active behavioral component, 
which results in an action that eliminates or reduces the source of stress.  
Therefore, active coping methods include coping efforts that others have referred 
to as problem-focused (Folkman & Lazarus, 1980), which are directed at altering 
the person-environment relationship, and emotion-focused (Folkman & Lazarus, 
1980), which are efforts directed at regulating the emotional response to the 
situation (Billings & Moos, 1981; Folkman & Lazarus, 1980; Goodkin et al., 
1992).  Problem-focused coping has been associated with less depression, fewer 
physical symptoms (Nakano, 1991), improved quality of life (Swindells et al., 
1999), and better immune function (McNaughton et al., 1990).  Avoidant coping, 
defined by Billings and Moos (1991), is referred to by some as Emotion-focused 
coping has been linked to anxiety, depression, emotional and physical distress 
(Compas et al., 1996), and poorer quality of life (Swindells, 1999).  However, in 
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some chronic stress conditions, both problem- and emotion-focused coping appear 
to have positive benefits of health and well-being (Ingledew et al., 1997).  Thus, 
the effects of coping may not depend as much on whether problem- or emotion-
focused coping styles are used, but rather if active or avoidant methods are 
utilized, particularly in situations of chronic stress, such as IBS. 
 For the purpose of this study, active coping is defined by the following: 
(1) Taking action; (2) Planning; (3) Seeking Instrumental Social Support; (4) 
Seeking Emotional Social Support; (5) Suppression of Competing Activities; (6) 
Religion; and (7) Positive Reinterpretation and Growth.  Avoidant coping is 
defined by the following: (1) Restraint Coping; (2) Resignation/ Acceptance; (3) 
Focus on and Venting of Emotions; (4) Denial; (5) Mental Disengagement; (6) 
Behavioral Disengagement; (7) Alcohol/Drug Use; and (8) Humor.   
5.3 Coping Research       
  The categorization of active versus avoidant coping has been used in 
further studies on health.  For example, (Stowell, Kiecolt-Glaser, & Glaser, 2001) 
conducted a cross-sectional study that investigated whether active or avoidant 
coping were differentially related to immune function depending on stress level.  
Perceived stress and coping was assessed in 173 healthy adults and related to 
immunological blood assays (the number and percentage of CD3, CD4, & CD8 T 
lymphocytes) as well as the proliferative response of peripheral blood leukocytes 
(PBL) to phytohemagluttinin (PHA) and concanavalin A (Con A).   Stowell et al. 
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(2001) found significant interactions between perceived stress and both coping 
methods on proliferation of PBL to mitogens PHA and Con A, indicating that the 
relationship between coping and proliferation to mitogens depends on stress level.  
Stowell et al. (2001) further found that, in general, active and avoidant coping 
were correlated with and increase in of PBL to PHA and Con A in individuals 
reporting high stress levels.  These results suggest that relationships between 
certain coping strategies and immune function depend on perceived stress level.     
 Jason, Witter, and Torres-Harding (2003) studied patients with chronic 
fatigue syndrome and examined coping style, optimism, and the amount and 
quality of social support.  Chronic fatigue syndrome, like IBS, is a functional 
disorder that can be extremely disabling and have major effects on an individual’s 
quality of life.  They found that those participants who expressed low ratings of 
optimism were likely to engage in avoidance coping behavior, while those with 
higher optimism ratings were more active in terms of daily activities and social 
interaction.  In addition, Jason et al. (2003) found that seeking information about 
the patient’s disorder, adapting behaviorally, and paying close attention to 
symptoms was characteristic of those with improved functioning.  
Summary  
 
 There are three main theoretical approaches to coping: person-based 
approach, situational determinant approach, and the cognitive approach.  Today, a 
majority coping research has adapted some aspects of the cognitive approach.   
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The cognitive approach identifies which coping strategies are used in a specific 
situation, and the conditions these strategies do or do not promote positive 
adaptation (Aldwin, 1999; Lazarus & Folkman, 1984).  The cognitive approach 
divides coping strategies into emotion-focused and problem-focused.  However, 
an adaptation of this by Billings and Moos’ notes that active versus avoidant 
coping appears to distinguish between successful and unsuccessful coping, and 
was the coping process utilized in this study.   
5.4 Literature Review Summary 
 The theoretical and conceptual frameworks of IBS are drawn from both 
medical and psychological disciplines.  Psychological factors that much of the 
current research is based, deal with personality traits, particularly dysfunctional 
adaptations such as depression and anxiety.  Studies of IBS have attempted to 
confirm the conventional assumption that stressors defined as an individual’s 
appraisal of their environment cause IBS.  However, the focus in recent years has 
been less on that connection than on a more proactive investigation of behavior 
modification to reduce the effects of stressors on their physical ability to function 
in their daily lives.   
 The Brain-Gut Axis hypothesis is the most recent approach to determining 
an answer to this question.  Burnett and Drossman (2005) found the Brain-Gut 
Axis to be a bi-directional association that incorporates enhanced motility, 
abnormal sensation, and automatic reactivity modulated by the central nervous 
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system brain (CNS) and gut (ENS).  The role IBS related symptom severity plays 
in furthering distress (anxiety & depression) is abundant in the literature and 
should be considered when evaluating the relationship between distress, coping, 
and IBS.  
 Coping may play a key role in the relationship between cognitive appraisal 
of IBS symptom severity and psychological distress.  Specifically, persons who 
utilize an avoidant coping style are found to be more distressed through an 
increase in anxious and depressive symptoms.  Stress (such as IBS symptoms) 
directly affects cognitive appraisal and therefore physiological functioning 
supported by the bidirectional “Brain-Gut Axis”.  Stress (such as IBS symptoms) 
can also affect treatment decisions and behaviors that can be associated with an 
increase in distress.  Coping style appears to play an important role in managing 
IBS related stressors.  For example, an individual utilizing an active coping style 
may adhere more to recommended treatment options, ask appropriate questions, 
and follow through with treatment decisions.  Furthermore, an individual utilizing 
avoidant coping may seek out negative coping strategies like alcohol 
consumption, denial, and/or withdraw from daily activities and interpersonal 
relationships.  This avoidant coping style may be a good indicator of persons who 
become distressed and seek treatment.  Therefore, training and education in more 
effective coping strategies may prevent an increase in anxiety and depression, 
decrease in IBS related symptom severity, increase effective decision making, and 
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increase a sense of control over their IBS diagnosis.  In addition, developing 
effective active coping skills may prevent distress long term in persons who suffer 
intermittent and consistent IBS symptomatology.   
 While active and avoidant coping have been researched in other functional 
disorder populations, such as chronic fatigue syndrome, there does not appear to 
be any current literature on active and avoidant coping style as a moderator of 
distress and stressors specific to IBS as measured by the IBS related symptom 
severity scale.  Most literature on IBS has focused more on the pathophysiological 
explanation for the onset and exacerbation of IBS related symptom severity.  
However, there does not appear to be substantial headway to differentiate and 
understand the inconsistency in the literature found among persons coping with 
IBS. 
 As the understanding of the mechanisms of IBS continues, treatment 
intervention studies in this population are increasingly needed.  An increase in 
treatment intervention studies cannot be properly implemented if coping style is 
not accurately evaluated and assessed in a clinical population.  The field is lacking 
a clear understanding of the relationship between distress, coping and IBS related 
symptoms.  Therefore, the question remains, does the type of coping style buffer 
or exacerbate the relationship between IBS symptom severity and psychological 
distress in a clinical IBS population?  The current study is designed to shed some 
light on these relationships. 
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   CHAPTER 6: THE PRESENT STUDY 
 
 A review of the literature suggests that there is a relationship between 
perceived stresses, IBS related symptomatology, and psychological distress, 
namely depressive and anxious symptoms.  However, the literature is lacking with 
regard to potential moderating variables, such as coping (active & avoidant), in 
the above relationship.  The literature would benefit from a greater understanding 
of the mechanisms that create the onset or exacerbation of IBS in a clinical 
population.  Therefore, the above research topics will help to understand 
inconsistencies in the research with regard to coping and psychological distress in 
the clinical IBS population.  As mentioned, previous studies found active coping 
to moderate the effects of stress on mental and physical health in other medical 
populations.  In contrast, avoidant coping has been associated with a 
magnification of the negative physical effects of stress on health and quality of 
life.  For the sake of future treatment interventions, it would be beneficial to know 
whether specific coping styles (active vs. avoidant) moderate the relationship 
between IBS related symptom severity and psychological distress. 
 Very few methodologically sound studies examine distress and coping in 
clinical IBS population.  Furthermore, presently no empirically validated 
treatments are available for the clinical IBS population.  Thus, a change in one’s 
coping may be an effective strategy for decreasing psychological distress (anxiety 
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& depression) and furthermore facilitate a reduction in IBS related symptom 
severity.  However, to our knowledge no one has yet examined or compared 
coping (active vs. avoidant) and how this may moderate the relationship between 
IBS related symptom severity and psychological distress (anxiety & depression) 
in a clinical IBS population taking antispasmodic medication.  
6.1 Hypotheses
1. Increased stressors (general & IBS specific) would positively relate with 
an increase in distress (i.e., anxious & depressive symptoms).  That is, 
perceived stress would account for a significant amount of variance in 
distress independent of medical and demographic variables.  Furthermore, 
IBS symptom severity would independently explain a significant amount 
of variance in distress over and above the variance explained by the first 
order effects of demographic, medical variables, and perceived stress 
alone.  
2. Active coping style would moderate the relationship between IBS 
symptom severity and psychological distress.  Thus, the interaction 
between IBS symptom severity and active coping would independently 
explain a significant amount of variance in distress over and above the 
variance explained by the first order effects of IBS symptom severity and 
active coping alone.  Furthermore, if an IBS patient reported a severe level 
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of IBS symptom severity, but had a more active coping style, then they 
would experience less psychological distress.  
3. Avoidant coping style would moderate the relationship between IBS 
symptom severity and psychological distress.  Thus, the interaction 
between IBS symptom severity and avoidant coping would independently 
explain a significant amount of variance in distress over and above the 
variance explained by the first order effects of IBS symptom severity and 
avoidant coping alone.  Furthermore, if an IBS patient reported a severe 
level of IBS symptom severity, but has a more avoidant coping style, then 
they would experience an increase in psychological distress.     
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CHAPTER 7: METHODS 
 
7.1 Participants: 
 One hundred and seven participants from the Regional Gastrointestinal 
Consultants, a large private GI practice in Yardley, Pennsylvania, were recruited 
for participation in this study and signed consent forms.  From this sample, 98 
(92%) of people with diagnosed IBS completed and returned their questionnaires 
over a five month period and included in this study.  Participants who met the 
following inclusion criteria participated in the study: eighteen years of age or 
older; diagnosed with an active case of IBS by means of by Rome II criteria and 
exclusion (i.e., physical exam, sigmoidoscopy, endoscopy or colonoscopy); 
receiving maintenance therapy with antispasmodic medication;  possess a sixth 
grade reading level; and the ability to speak and read English 
Participants were excluded if they had an active diagnosis of psychosis or 
psychotic symptoms; an organic gastrointestinal disorder in the past 365 days; 
and/or refused or unable to provide informed or written consent. 
 Of the 98 participants, 60.2% (59) were female and 39.8% (39) were male.  
Participants ranged in age from 18-74 with 29.6% between 18-44 years of age and 
70.4% from 45-74 years of age.  Overall, 92.8% (N=90) of the participants were 
Caucasian, 4.1% were Hispanic (N=4), 2.1% (N=2) African American and 1.0% 
(N=1) were another race.  All of the participants in the sample were at least eighth 
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grade graduates, 42.8% (N=42) of the participants a college degree and 22.4% 
held a professional degree (J.D., Ph.D., M.D., M.B.A.).  The majority of the 
participants (72%) had an annual income greater than or equal to $52,000, of that 
20.4% had an annual income greater than $120,000.  Regarding religion, 41.8% 
were Catholic, 31.55% were Christian, 7.1% were Jewish, and 26.5% reported no 
religion.  Seventy percent of the sample were married, 19.4% were single, 7.1% 
were divorced, and three were widowers.  All participants 100% (N=98) were 
currently taking antispasmodic medication for their IBS related symptoms.  
Regarding caffeine intake, 74.5% (N=25) drank caffeine on a daily basis and 
25.5% (N=25) reported no caffeine consumption.  Of the participants sixty-six 
percent had never received psychological services with 34% (N=33) receiving 
psychological services at some point in their lifetime.  No participants reported 
receiving psychological services particularly for their IBS symptoms.  None of the 
participants reported having a history of inpatient psychiatric services.   
 The participants sampled in this study were diagnosed with IBS ranging 
from one month to forty-four years (M = 6 years, SD = 7.21 years).  Thirty-five 
percent (N=33) of participants were diagnosed with IBS for less than or equal to 
one year, with 47.3% (N=47) diagnosed with IBS 1-10 years, and 15% (N=14) 
participants diagnosed 10-20 years.  Regarding level of IBS symptom severity, 
16.3% of participants endorsed a score less than 75, 34.7% or (N=34) endorsed 
mild IBS symptomatology (score 76-175), 29.6% (N=26) indicated moderate IBS 
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symptom severity (score 176-300), and 19 participants (19.4%) endorsed severe 
IBS symptomatology (301-500). 
7.2 Procedure 
 Participants for the current study were volunteers, recruited from the 
Regional Gastrointestinal Consultants, a large private GI practice in Yardley, 
Pennsylvania.  The gastroenterologist, Dr. Fanelli, identified patients with a 
diagnosis of IBS, meeting the inclusion/exclusion criteria, using his medical files 
and professional expertise.  During the patient’s visit, Dr. Fanelli informed the 
qualified patients about an opportunity to partake in a study on IBS at his center.  
Dr Fanelli informed the patient if he/she wanted to learn more about the study the 
patient could approach the research assistant located in the office.  Dr. Fanelli 
reassured the patient that participation was at his/ her own discretion and would 
not affect his/her treatment (current or future) in any way.   
When the patient approached the researcher in the private medical office, 
it was described to the participant of the intent of the research study that would 
include answering a series of questionnaires that concentrated on thoughts, 
feelings and behaviors related to IBS.  After reviewing the study verbally with the 
participant, the participant was asked to read and sign the consent form to 
participate in the study.  Participants were informed that signing the consent form 
allowed the research assistant access to their medical chart at the Regional 
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Gastrointestinal Consultants.  The questionnaires (described under “Measures”) 
took approximately 40 minutes to complete. 
 The participants were made aware of psychological services available to 
them.  The potential risks of this study were explained as having the potential to 
become emotionally upset or uncomfortable answering questions about their 
thoughts, feelings and behaviors regarding their IBS.  Therefore, in order to 
minimize risks, confidentiality was emphasized and protected.  For example, 
measures were identified with numbers and locked in a cabinet and participants 
were approached during their private consultation with Dr. Fanelli rather than in a 
public waiting room.  Furthermore, referrals for psychological services were 
offered to all participants. 
7.3 Measures 
7.3.1 Coping
Coping:  The COPE Inventory (Carver, Scheier, & Weintraub, 1989)  
 The full COPE is a 60-item measure that reflects 15 factors that represent 
active versus avoidance coping strategies.  In the "traitlike" version, respondents 
were asked to rate the degree to which they typically use each coping strategy 
when under stress.  In the "statelike" version, respondents rate the degree to which 
they use each coping strategy to deal with a particular stressful event.  Ratings are 
made on a 4-point Likert-type scale that ranges from "I (usually) don’t do this at 
all" (1) to "I (usually) do this a lot" (4).  The measure has good psychometric 
 
Page 61 of 153  
Coping and Irritable Bowel Syndrome 
properties with alphas ranging from .45 to .92, test-retest reliabilities ranging from 
.46 to .86, and strong evidence of discriminate and convergent validity, with 
constructs such as hardiness, optimism, control, and self-esteem (see Appendix E)  
for the COPE scales).    
 Participants completed the COPE Inventory in reference to their IBS 
related symptoms.  The COPE Inventory was used in a sample of IBS patients by 
Ebert, et al.  (2002); and by Jason et al. (2003) to study patients with Chronic 
Fatigue Syndrome; and by Stanton, Danoff-Burg, Cameron et al. (2000) in breast 
cancer patients.  Rutter and Rutter (2002) utilized the dispositional format of the 
instrument to measure illness representations in IBS patients.  This measure was 
utilized to assess the style of coping (active or avoidant) patients employed.  The 
scale had high reliability, with an overall Chronbach’s alpha coefficient of .86.  
Furthermore, the active and avoidant scales had fair reliability, with an overall 
Chronbach’s alpha of .72 and .75 respectively. 
7.3.2 Distress 
Depressive symptoms:  Beck Depression Inventory-Second Edition (BDI-II) 
(Beck, Steer, & Brown, 1996)  
 The Beck Depression Inventory-II is a 21-item self-report measure of 
depressive symptoms that was developed according to criteria for depressive 
disorders found in the DSM-IV.  This measure was used to assess current level of 
depression in IBS patients.  The BDI-II is a widely used measure in both clinical 
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and research settings.  Higher scores represent higher levels of depressive 
symptoms and all 21 items are summed.  Cutoff scores can be utilized to serve as 
guidelines: (0-13), mild depression (14-19), moderate depression (20-28), and 
severe depression (29-63).  None of the items of the BDI overlap with the IBS-SS. 
 The psychometric properties were studied on two samples: a group of 500 
patients (317 men; 183 women) from four psychiatric outpatient facilities and a 
group of 120 college students (67 men; 53 women).  With regards to reliability, 
coefficient alphas for internal consistency were found to be .92 and .93 for the 
psychiatric outpatient sample and .93 for the college students.  Test-retest 
reliability was estimated to be .93.  The BDI-II was also found to correlate 
strongly with other depression measures and constructs, such as the Hamilton 
Rating Scale for Depression (.71) and a measure of hopelessness (Beck 
Hopelessness Scale, .68).  The BDI-II was used to assess the severity of 
depressive symptomatology clinical IBS patients endorsed at time of assessment. 
7.3.3 Anxious Symptoms  
State Trait Anxiety Inventory (STAI) (Speilberger, Gorush, Luschene, Vagg, & 
Jaccobs, 1983)  
 The State Trait Anxiety Inventory was used to measure state and trait 
anxiety in persons diagnosed with IBS.  Speilberger (1970) distinguishes between 
current feelings of anxiety (‘state’ anxiety) and more generalized feelings of 
anxiety (‘trait’ anxiety).  This inventory consists of two distinct scales, the state 
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and trait scales; each consists of 20 statements that require the participant to rate 
each statement on a four-point scale.  The State Anxiety Scale (STAI-S) evaluates 
feelings of apprehension, tension, nervousness, and worry at the present time.  
This scale has been used in situations of real-life stressors such as dental 
treatment, imminent surgery and job interviews.   
 The Trait Anxiety Scale (STAI-T) has been widely used in assessing 
clinical anxiety in medical, surgical, psychosomatic and psychiatric patients.  
With regard to test-retest reliability, it is shown to be high for the STAI-T Anxiety 
scale and low for the STAI scale.  Furthermore, this measure has been shown to 
have good concurrent, convergent, divergent and construct validity.  The 
coefficients for the Trait Anxiety scale ranged from .65 to .86, whereas State 
Anxiety scale ranged from .16 to .62.  Items on the State Anxiety scale responses 
are thought to reflect the influence of whatever passing situational factors exist at 
the time of testing.  Therefore, this low level of stability for the State-anxiety 
scale is expected.  For the purposes of this study both the State and Trait portion 
of the measure was utilized to examine level of state anxiety (current) and trait 
anxiety (general) symptoms in this clinical IBS population. 
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7.3.4 Stressors 
Irritable Bowel Syndrome Physical Symptom Severity:   Irritable Bowel Severity 
Scoring System (IBS-SS) (Francis, Morris, & Whorwell, 1997)  
 The Irritable Bowel Severity Scoring System is specifically intended to 
assess the severity of IBS related symptoms in a patient at a particular point in 
time for a symptom severity score, bowel habits, and pain.  The measure rates the 
severity of five symptoms on a visual analog scale ranging from 0 to 100.  The 
scale assesses the following features: (1) overall severity of abdominal pain, (2) 
frequency of abdominal pain of average severity over the last 10 days, (3) severity 
of abdominal distension/ tightness, (4) patient satisfaction with bowel habits, and 
(5) impact that the IBS related symptoms have on day-to-day quality of life.  
Controls scored below 75 and persons diagnosed with IBS who score in the range 
of 0-75 is considered low symptomatology.  Mild cases have a score of 75-175; 
moderate, 175 to 300; and severe, greater than 300.  In the development of the 
IBS-SS there was a highly significant difference between controls and IBS 
patients (p=0.0001) as well as significant differences (p<0.01) between all 
severity categories.  Sensitivity to change scores were also excellent (p<0.001) 
with a change of 50 indicating improvement.  For the purposes of this study the 
IBS-SS was used to measure level of IBS symptom severity at the time of intake 
(see Appendix H). 
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7.3.5 Perceived Stress   
 The Perceived Stress Scale (PSS) (Cohen, Kamarck, & Mermelstein, 
1983)  
 The PSS was used to measure IBS patient’s interpretation of perceived 
general life stress over the past month and used as a covariate in this study.  This 
interpretation is assessed globally, not in relation to specific events.  The PSS is a 
14-item self-report questionnaire.  The participants rate each item on a 5-point 
Likert scale ranging from 0 (never) to 4 (very often).  The PSS produces a total 
score with a range from 0 to 56.  Higher scores are indicative of greater perceived 
stress.  The PSS generally takes no more than three minutes to complete. 
 The PSS was found to have high reliability and moderate validity.  A 
study of the general population produced an internal consistency of .75.  Test-
retest reliability for college students with a six-week lapse was .55.  Concurrent 
validity (as compared to the Maslach Burnout Inventory) was found to be .65.  
Furthermore, the PSS has found to be correlated with both constructs of anxiety 
and depression (from .5 to .8).  For the purpose of this study, the PSS was utilized 
as a covariate to partial out general perceived stressors from IBS related stressors 
(see Appendix I). 
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7.3.6 Demographic Sheet 
 A demographic questionnaire gathered specific information related to 
general demographic information of the patients, such as age, gender, race, 
socioeconomic status, caffeine intake, history of psychological services.  Patients 
were asked basic IBS related questions such as gastrointestinal diagnosis, 
treatment, and duration of IBS diagnosis.  Some of these variables served as 
controls (see Appendix J). 
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   CHAPTER 8: DATA ANALYSIS 
 
 Data was analyzed using SPSS 14.0 statistical package.  Univariate 
analyses examined each variable to assess skew and presences of outliers.  The 
means, standard deviations, minimum, maximum, skew and kurtosis for perceived 
stress, IBS symptom severity, coping style (active & avoidant), and distress 
(depression & anxiety scales) are presented in Table 1.  No outliers were found 
and normal variable distributions were present.  Prior to conducting hierarchical 
multiple regression analyses, Cohen and Cohen (1993) recommend assessment of 
multicollinearity among predictor variables with correlations above .80 and 
considered this problematic suggesting measurement of the same construct.  
Correlations among predictor variables were not problematic in this study.  
Furthermore, outcome variables with a correlation above .60 should have call for 
concern.  There was a significant correlation between the outcome variables 
depression, state anxiety, and trait anxiety.  Therefore, a data reduction was 
conducted using principal component factoring on the three dependent variables 
(i.e., BDI, State Anxiety, & Trait Anxiety) to determine a single distress factor 
used in this study. 
 As noted by Aiken and West (1991), an assumption of moderation 
analyses is the significant correlation between the independent variables and 
dependent variables tested.  For this purpose, Pearson’s product-moment 
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correlational analyses were conducted to calculate the relationship between the 
variables being tested (i.e., stressors, distress, & coping style) and are presented in 
Table 2.  Therefore, to assess for further potential confounding variables, 
correlational analyses were conducted between tested variables and demographic 
information presented in Table 3.    
 The initial correlations demonstrated relatively expected outcomes.  First, 
previous research had indicated that both perceived stress and IBS symptom 
severity significantly related to distress (Houghton, Heyman, & Whorwell, 1996).  
There was a strong positive relationship between perceived stress and the 
dependent variable distress.  Furthermore, irritable bowel symptom severity 
significantly and positively related to distress.  Second, age significantly related to 
distress.  Age and gender positively related to active coping.  Furthermore, time 
diagnosed with IBS positively related to irritable bowel symptom severity.  
Therefore, demographic variables that significantly correlated with distress (age) 
or variables determined a priori were controlled for (gender & duration of IBS), 
were controlled for in each of the hierarchical regression analyses. 
 Moderated regression analyses, as the recommended method for testing 
interaction effects, were used (Cohen & Cohen, 1983; Baron & Kenny, 1986; 
Landsbergis et al., 1994).  Hierarchical multiple regression analyses were 
conducted to determine the first order effects and interaction effects of IBS related 
symptom severity on distress.  In order to test interaction effects, multiplicative 
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terms were created from the standardized independent variables (Baron & Kenny, 
1986; Aiken & West, 1991; Cohen & Cohen, 2003, Baron et al., 2004).  
8.1 Hypothesis 1 
  This hierarchical regression analysis was conducted to verify the unique 
variance IBS related symptom severity had with psychological distress 
(depression, state anxiety & trait anxiety).  The standardized independent 
variables were introduced into the equation in three successive steps to control for 
potentially confounding variables (Aiken & West, 1991; Cohen et al., 2003; 
Holmbeck, 1997; Jaccard et al., 1990; Baron et al., 2004).  In the first step (1), 
demographic variables that correlated significantly or thought to have a 
relationship to the distress factor a priori were entered first into the equations 
(age, gender, time diagnosed).  Next (2), perceived stress, followed by (3), IBS 
symptom severity, were then entered into the equation. 
 Hypotheses (2) and (3) were related to the moderating role of coping 
styles on the relationship between irritable bowel related symptom severity and 
distress.  To test these hypotheses, two separate hierarchical regressions were 
conducted, one for each coping style (active & avoidant) on the distress factor. 
8.2 Hypotheses 2  
 In the hierarchical regression analysis, the dependent variable was distress.  
The standardized independent variables were introduced into the equation in five 
successive steps to control for potential confounding variables (Aiken & West, 
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1991; Cohen et al., 2003; Holmbeck, 1997; Jaccard et al., 1990; Baron et al., 
2004).  In the first step (1), demographic variables that correlated significantly or 
thought to have a relationship to the distress factor a priori were entered first into 
the equations (age, gender, time diagnosed).  Next (2), perceived stress was 
entered, followed by (3), irritable bowel symptom severity (4), the moderator 
variable active coping, and finally (5) the interaction of irritable bowel symptom 
severity X active coping style.  Significance levels for all data analyses were set a 
priori at a .05 alpha level. 
8.3 Hypotheses 3 
 In the hierarchical regression analysis, the dependent variable remained 
distress.  The standardized independent variables were introduced into the 
equation in five successive steps to control for potentially confounding variables 
(Aiken & West, 1991; Cohen et al., 2003; Holmbeck, 1997; Jaccard et al., 1990; 
Baron et al., 2004).  In the first step (1), demographic variables that correlated 
significantly or thought to have a relationship to the distress factor a priori were 
entered first into the equations (age, gender, time diagnosed).  Next (2), perceived 
stress was entered, followed by (3), irritable bowel symptom severity (4), the 
moderator variable avoidant coping, and finally (5) the interaction of irritable 
bowel symptom severity X avoidant coping style.  Significance levels for all data 
analyses were set a priori at a .05 alpha level. 
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8.4 Data Reduction 
 Due to the significant correlation between depression, state anxiety and 
trait anxiety, a factor analysis was conducted using principal component factoring 
on the three dependent variables measuring symptoms of distress (i.e., BDI-II, 
State Anxiety, & Trait Anxiety).  Only one eigenvalue was greater than 1.0, and 
this one factor was retained.  The factor accounted for 82.27% of the variance in 
the dependent variables.  The retained factor was labeled distress.  This factor 
analysis was completed to minimize the number of multiple regression analyses 
completed, in an attempt to minimize a Type I error.   
 Questions that loaded onto this one eigenvalue consisted of questions rated 
by participants on a 4-point likert scale and asked them how they had been feeling 
over the past two weeks.  For example, questions asked, “I feel inadequate” “I 
feel nervous and restless” “I am tense” “I have disturbing thoughts” “irritability.”  
The factor loadings were: BDI (.355), State anxiety (.364), and Trait anxiety 
(.384). 
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    CHAPTER 9:  RESULTS  
 
9.1 Descriptive Statistics 
 The means, standard deviations, minimum, maximum, skew and kurtosis 
information for irritable bowel symptom severity, coping style, state anxiety, trait 
anxiety, and depression measures (N=98) are presented in Table 1.  All variables 
demonstrated a relatively normal distribution, except for the Beck Depression 
Inventory (depression).  As might be expected with a measure examining the 
severity of one’s level of depression in a clinical IBS population, the BDI was 
negatively skewed, indicating that most of the participants experienced several 
symptoms of depression in the past two weeks, while a small proportion of 
participants experienced only a few symptoms of depression. 
9.2 Bivariate Analysis of Independent & Dependent Variables 
 Correlational coefficients for independent variables (i.e., IBS symptom 
severity & coping style) and the dependent variable distress (N=98) are displayed 
in Table 2.  (1) There was a strong positive correlation between irritable bowel 
symptom severity and distress (r = .35, p<.01).  (2) Perceived stress was 
significantly and positively correlated to the dependent variable distress (r = .34, 
p<.01).  (3) Furthermore, active coping was negatively correlated to irritable 
bowel symptom severity (r = -.23, p<.05).  (4) However, neither active coping (r = 
-.13, p= .212) nor avoidant coping (r = .17, p=.08) were independently and 
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significantly correlated to distress.  In moderation analysis, Baron and Kenny 
(1986), note it is most desirable to have the moderator variable (coping style) not 
significantly correlated with either the predictor variable (IBS symptom severity) 
or the criterion variable (distress) to attain the most interpretable interaction.  
However, if a significant correlation exists, one can continue with the statistical 
analyses.  There were no significant correlations between the predictor variables 
and the criterion variable, except for the relationship between active coping and 
IBS symptom severity which was at significance (p=.05).  Therefore, it was 
appropriate to conduct the hierarchal regression analyses with the interaction for 
active coping. 
9.3 Analysis of Multicollinearity and Potentially Confounding Variables 
 In an attempt to assess for multicollinearity and potential confounding 
variables, bivariate correlations were conducted between demographic variables, 
measures of stressors, coping style, and distress (N=98).  Results are presented in 
Table 3.  Age was significantly and negatively correlated to distress (r =-.27, 
p<.01) and active coping (r = .24, p<.05).  Gender was positively correlated to 
active coping (r = .20, p<.05).  Furthermore, time diagnosed with IBS was 
positively correlated to irritable bowel symptom severity (r = .22, p<.05).  
Therefore, demographic variables significantly correlated with distress (age) or 
variables determined a priori to be controlled for (gender & duration of IBS), 
were controlled for in subsequent analyses. 
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9.4 Relationship between Symptom Severity and Distress 
Hypothesis 1 
 The overall model was significant (N=98) and accounted for 25.4% of the 
variance in distress F (5, 92) = 6.26, p<.01.  Demographic variables that 
significantly correlated with distress or variables determined a priori were 
controlled for (i.e., age, gender, & years diagnosed) significantly accounted for 
8.8% of the variance in distress F (3, 94) = 3.02, p=.034.  The addition of 
perceived stress to the demographic variables led to an independent significant 
increase in the variance accounted for by the model R²= .195, ΔR²= .107, F change 
(1, 93) = 12.33, p=.001.  Thus, perceived stress independently explained an 
additional 10.7% of the variance in distress over and above the 8.8% explained by 
the first order effects of the demographic and medical variables.  When irritable 
bowel symptom severity was added to the equation, the total model accounted for 
25.4% of the variance in distress ΔR²= .059, F change (1, 92) = 7.3, p=.008.  
Therefore, irritable IBS symptom severity independently explained an additional 
5.9% of the variance in distress over and above the 19.5% explained by the first 
order effects of the demographic and medical variables, and perceived stress.  The 
coefficients for all variables in this model are presented in Table 4. 
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9.5 Relationship between Active Coping, Irritable Bowel Symptom Severity and 
Distress 
Hypothesis 2  
 With regard to active coping (N=98), the overall model accounted for 
28.8% of the variance in distress R²= .288, F (7, 90) =5.20, p< .01.  Active coping 
did not have a significant first order effect on distress over and above irritable 
bowel symptom severity, perceived stress, medical and demographic variables (β 
(1, 91) = -.071, t = -.715, p= .476).  However, the interaction between active 
coping and irritable bowel symptom severity independently explained a 
significant amount of variance in distress (β (1, 90) = .186, t= 2.05, p= .044).  
Therefore, the interaction between active coping and IBS symptom severity 
accounted for an additional 3.3% of the variance in distress over and above the 
25.5% of the variance explained by the first order effects of the demographic and 
medical variables, perceived stress, and IBS symptom severity alone.  The 
coefficients for all variables in this model are presented in Table 5. 
 To understand the significant interaction between active coping and IBS 
symptom severity, post-hoc probing of the interaction, as suggested by Aiken and 
West (1991), through computation of the simple slopes, was conducted.  Cohen et 
al. (2003) recommends plotting the predicted values of IBS symptom severity and 
distress at three differing levels of active coping.  Aiken and West (1991), Cohen 
and Cohen (2000), and Baron and Kenny (1986) suggest the calculation of the 
 
Page 76 of 153  
Coping and Irritable Bowel Syndrome 
simple regression lines at the mean, one standard deviation above (+1 SD), and 
one standard deviation below (-1 SD) level of active coping.  The simple 
regression values and slopes for active coping are displayed in Figure 9.  
 As can be seen by Figure 10, at high levels (+1 SD) of IBS symptom 
severity, low levels (-1 SD) of active coping are related to higher levels of 
psychological distress, as compared to mean or high levels (+1 SD) of active 
coping.  At mean levels of IBS symptom severity, high level (+1 SD) of active 
coping is associated with higher levels of psychological distress than either mean 
or low levels (-1 SD) of active coping.  Interestingly, at low levels of IBS 
symptom severity, there appears to be an inverse relationship between level of 
active coping style and distress, where lower levels (-1SD) of active coping are 
associated with lower levels of distress.  When the t-test for simple slopes was 
conducted, mean levels of active coping (β = 0.241, p< 0.01) and low levels of 
active coping (β = 0.396, p< 0.005) were significantly different from zero. 
However, the simple slope for high levels of active coping (β = .86, ns) was not 
significant from zero, indicating that high levels of active coping had the potential 
to essentially eliminate relations between IBS symptom severity and distress. 
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9.6 Relationship between Avoidant Coping, irritable bowel symptom severity and 
Distress 
Hypothesis 3 
 With regard to avoidant coping (N=98), the overall model accounted for 
34.2% of the variance distress R²= .342, F (7, 90) = 6.68, p<.01.  Avoidant coping 
was independently significantly related to distress over and above irritable bowel 
symptom severity, perceived stress, medical and demographic variables ΔR²= 
.041, F change (1, 91) = 5.28, p= .024.  Therefore, avoidant coping independently 
significantly predicted 4.1% of the variance in distress over and above the 25.4% 
explained by the first order effects of the demographic, medical variables, 
perceived stress, and IBS symptom severity.  Furthermore, the interaction 
between avoidant coping and irritable bowel symptom severity independently 
explained a significant amount of variance in distress (β (1, 90) =.221, t= 2.54, 
p=.013).  Therefore, the interaction between avoidant coping and IBS symptom 
severity explained an additional 4.7% of the variance in distress over and above 
the 29.5% of the variance explained by the first order effects of the demographic, 
medical variables, perceived stress, IBS symptom severity, and avoidant coping 
alone. The coefficients for all variables in this model are presented in Table 6. 
 Again, simple slopes analyses were conducted to examine the moderating 
role of avoidant coping and IBS symptom severity.  Levels of IBS symptom 
severity and distress were tested at mean, one standard deviation above (+1 SD), 
 
Page 78 of 153  
Coping and Irritable Bowel Syndrome 
and one standard deviation below (-1 SD) levels of avoidant coping.  The simple 
regression values and slopes for avoidant coping are displayed in Figure 11.  
 As can be seen by Figure 12, at high levels (+1 SD) of IBS symptom 
severity, high levels (+1 SD) of avoidant coping are related to higher levels of 
psychological distress, as compared to mean or low levels (-1 SD) of avoidant 
coping.  At mean levels of IBS symptom severity, high levels (+1 SD) of avoidant 
coping continued to be associated with higher levels of psychological distress as 
compared to either mean or low levels (-1 SD) of avoidant coping.  Interestingly, 
at low levels of IBS symptom severity, level of avoidant coping style (low, mean, 
& high) does not appear to differ in their association with level of psychological 
distress.  When the t-test for simple slopes was conducted, high levels of avoidant 
coping (β = 0.492, p< 0.005) and mean levels of avoidant coping (β = 0.270, p< 
0.005) were significantly different from zero.  However, the simple slope for low 
levels of active coping (β = .048, ns) was not significant from zero, indicating that 
low levels of active coping had the potential to essentially eliminate relations 
between IBS symptom severity and distress. 
 To examine whether the interaction between active or avoidant coping 
style was more significant in predicting psychological distress, a test for parallel 
slopes was conducted (N=98).  It was found that the mean slope of avoidant 
coping (β = 0.270) was statistically larger than the mean slope for active coping (β 
= 0.241) paired t = 2.2133, df = 94, P<0.025.  This suggests that avoidant coping 
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affects the relationship between levels of IBS symptom severity and 
psychological distress at significantly larger intervals.  Such that a clinical IBS 
patient who endorses more avoidant coping strategies will experience higher 
levels of psychological distress more quickly then one who utilizes a more active 
coping style with the same level of IBS symptom severity.  This relationship 
appears to become more apparent at mean and high levels of IBS symptom 
severity.   
9.7 Post-Hoc Tests  
Relationships between IBS Symptom Severity, Coping, Trait Anxiety and 
Depression 
 The significant moderation of both active and avoidant coping style on the 
relationship between IBS symptom severity and distress warrants further 
exploration of these above relationships.  To gain a better understanding of the 
specific relationship IBS symptom severity and coping style had on distress, 
depression and anxiety were examined independently. 
9.7.1 Relationship between Irritable Bowel Symptom Severity and Depression 
 The overall model (N=98) was significant, and accounted for 17.7% of the 
variance in depression F (5, 92) = 3.95, p<.01.  Demographic variables (i.e., age, 
gender, & years diagnosed) did not have a significant first order effect on 
depression (F (3, 94) = 2.39, p=.073).  The addition of perceived stress to the 
demographic variables led to a significant increase in the variance accounted for 
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by the model R²= .130, ΔR²= .059, F change (1, 93) = 12.6.33, p= .014.  Thus, 
perceived stress independently significantly accounts for 5.9% of the variance in 
depression.  When irritable bowel symptom severity was added to the equation, 
the total model accounted for 17.7% of the variance of depression ΔR²= .047, F 
change (1, 92) = 5.22, p=.025.  Therefore, irritable IBS severity independently 
significantly accounts for 4.7% of the variance in depression over and above the 
13% of the variance accounted for by perceived stress and certain medical and 
demographic variables.  This independent significant relationship between 
perceived stress and IBS symptom severity on depression warrants further 
investigation of coping in the above relationship.  The coefficients for all 
variables in this model are presented in Table 7. 
9.7.2 Relationship between Active Coping, Irritable Bowel Symptom Severity and 
Depression 
 With regard to active coping, the overall model (N=98) accounted for 
22.8% of the variance in depression R²= .228, F (7, 90) = 3.79, p< .01.  Active 
coping did not independently significantly account for the variance in depression 
above the first order effects if irritable bowel symptom severity, perceived stress, 
medical and demographic variables (β (1, 91) = -.001, t = -.013, p= .990).  
However, the interaction between active coping and irritable bowel symptom 
severity independently explained a significant amount of variance in depression (β 
(1, 90) = .229, t= 2.41, p= .018).  Thus, active coping was a significant moderator 
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of the relationship between irritable bowel symptom severity and depression.  The 
coefficients for all variables in this model are presented in Table 7. 
9.7.3 Relationship between Avoidant Coping, Irritable Bowel Symptom Severity 
and Depression 
 With regard to avoidant coping, the overall model (N=98) accounted for 
30.6% of the variance in depression R²= .306, F (7, 90) = 5.67, p=.017.  There 
was a independent and significant first order effect of avoidant coping on 
depression over and above irritable bowel symptom severity, perceived stress, 
medical and demographic variables ΔR²= .084, F change (1, 91) = 10.31 p= .002.  
Furthermore, the interaction between avoidant coping and irritable bowel 
symptom severity independently explained a significant amount of variance in 
depression (β (1, 90) = .216, t= 2.42, p= .017).  Thus, avoidant coping was a 
significant moderator of the relationship between irritable bowel symptom 
severity and depression.  The coefficients for all variables in this model are 
presented in Table 7. 
9.7.4 Relationship between Irritable Bowel Symptom Severity and Trait Anxiety 
 The overall model (N=98) was significant, accounting for 25.2% of the 
variance in Trait Anxiety F (5, 92) = 6.21, p=.014.  There was an independent 
significant first order effect of demographic variables (i.e., age, gender, & years 
diagnosed) on trait anxiety F (3, 94) = 3.23, p=.026.  Perceived stress 
independently significantly accounted for 10.8% of the variance in trait anxiety 
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R²= .202, ΔR²= .108, F change (1, 93) = 12.62, p= .001.  When irritable bowel 
symptom severity was added to the equation, the total model accounted for 25.2% 
of the variance of trait anxiety ΔR²= .05, F change (1, 92) = 6.21, p=.014.  
Therefore, irritable bowel related symptom severity independently significantly 
accounted for 5% of the variance in trait anxiety above the 20.2% of the variance 
accounted for by perceived stress and certain medical and demographic variables 
alone.  The coefficients for all variables in this model are presented in Table 7. 
9.7.5 Relationship between Active Coping, Irritable Bowel Symptom Severity and 
Trait Anxiety 
 With regard to active coping, the overall model (N=98) accounted for 
28.1% of the variance in trait anxiety R²= .281, F (7, 90) = 5.02, p=.072.  There 
was not a independent significant first order effect of active coping on trait 
anxiety over and above irritable bowel symptom severity, perceived stress, 
medical and demographic variables (β (1, 91) = -.081, t = -.806, p= .422).  
Furthermore, the interaction between active coping and IBS severity did not 
independently explain a significant amount of variance in trait anxiety (β (1, 90) = 
.167, t= 1.82, p= .072).  Thus, active coping was not significant moderator of the 
relationship between IBS severity and trait anxiety.  The coefficients for all 
variables in this model are presented in Table 7. 
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9.7.6 Relationship between Avoidant Coping, Irritable Bowel Symptom Severity 
and Trait Anxiety 
 With regard to avoidant coping, the overall model (N=98) did account for 
34.2% of the variance in trait anxiety R²= .342, F (7, 90) = 6.69, p=.009.  There 
was a independent and significant first order effect of avoidant coping on trait 
anxiety over and above irritable bowel symptom severity, perceived stress, 
medical and demographic variables (ΔR²= .038, F change (1, 92) = 4.82, p=.031).  
Furthermore, the interaction between avoidant coping and irritable bowel 
symptom severity did independently explain a significant amount of variance in 
trait anxiety (β (1, 90) = .232, t= 2.68, p= .009).  Thus, avoidant coping was a 
significant moderator of the relationship between irritable bowel symptom 
severity and trait anxiety.  The coefficients for all variables in this model are 
presented in Table 7. 
 The finding that active coping was an independent and significant 
moderator between IBS symptom severity and depression, but not IBS symptom 
severity and anxiety warrants further exploration.   
9.7.7 Gender Comparisons 
 Independent samples t-tests were conducted to evaluate gender differences 
with regard to the independent variables (PSS, IBS-SS) and dependent variables 
(distress, depression, STAI-S, STAI-T).  The independent samples t-test (N=98) 
indicated that the means for distress, depression, state anxiety, trait anxiety, PSS, 
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IBS-SS, and avoidant coping did not differ significantly at the p<.05 level 
between males and females.  The Levene’s test for Equality of Variances (N=98) 
indicated variances for males and females did not differ significantly from each 
other across all factors.  However, the independent samples t-test (N=98) analysis 
did indicate there was a significant difference (t=-2.02, p=.046) in level of active 
coping between the 59 females (M= 72.89, SD=14.94) and the 39 males (M= 
66.15, SD=18.68) (see Figure 8). 
 Though this finding may be of some interest, this study did not explore 
gender in subsequent analyses.  There are several possible explanations for this 
significance.  First, the gender split was 60% females and 40% males; second, 
though the mean is statistically different, the standard deviation for males is 
greater then that of females.  Thus, upon further review of the frequencies of 
active coping by gender (see Figure 8) it appears that there is a similar trend in the 
curve for both males and females.  It would be interesting to see if a significant 
difference in active coping style would occur with equal sample sizes for males 
and females.  For the purpose of this study, gender differences were controlled for 
in the hierarchal multiple regressions by entering gender into he first level of the 
regression analyses. 
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  CHAPTER 10: DISCUSSION 
 
 An estimated 30-60 million American adults suffer from IBS at any 
given time.  IBS is the most common of the functional disorders, accounting for 
12% of visits to primary care physicians and 28% of referrals to 
gastroenterologists.  Only in the past 20 years has IBS been considered a 
clinical disorder, with treatment options both medical and psychological in 
nature and not a syndrome that was “all in your head”.  However, no single 
treatment is successful in the reduction of IBS symptom severity.  IBS suffers 
may feel that they are alone having to manage the “trial and error” approach to 
treating their IBS related symptoms which may lead to ambiguity, isolation, and 
frustration.  Therefore, when symptoms of IBS become apparent, individuals are 
faced with a multitude of challenges and medical decisions such as costly and 
frequent medical appointments, invasive and potentially painful medical 
procedures, social and occupational disruptions, and significant psychological 
distress.  IBS patients in this study displayed great frustration with the lack of 
control over their illness and daily lives.  The unpredictability of IBS 
exacerbations, severity of symptoms, and lack of understanding and empathy 
for their illness by family, coworkers, and physicians lead to feelings of 
disappointment, anger, and frustration.  Due to the significant disruption IBS 
can create in one’s life, and the number of individuals suffering with IBS at any 
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given time, it is important to acknowledge, assess, and intervene with this 
population.  The intervention of individuals with IBS is an attempt to minimize 
the physical and psychological distress created by IBS symptom severity, 
decrease depression and anxiety, improve quality of life, and decrease the 
chances of suffering a subsequent bought of IBS.   
 Understanding why some individuals who seek treatment for IBS become 
psychologically distressed and others do not, has received marginal attention.  
Furthermore, this population is in need of empirically supported treatment 
interventions.  Thus, the purpose of this study was to explore the direct 
association between levels of perceived stress and IBS symptom severity on 
levels of psychological distress.  Furthermore, we investigated whether active and 
avoidant coping styles differentially affected the relationship between IBS 
symptom severity and psychological distress in clinical IBS population receiving 
antispasmodic medical treatment for their IBS symptomatology.  
 To summarize, several significant relationships were found in this study.  
The first hypothesis suggested both perceived stress and IBS symptom severity 
would significantly and positively be associated to levels of distress.  Perceived 
stress was significantly and independently associated to distress above 
demographic and medical variables alone.  Furthermore, IBS symptom severity 
significantly and positively relates to distress over demographic variables and 
general perceived life stress.  These findings allowed us to reject the null 
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hypothesis suggesting no significant relationship between perceived stress, IBS 
symptom severity and psychological distress exists.  Furthermore, a significant 
and positive relationship between levels of IBS symptom severity and 
psychological distress, taking into account general perceived life stress, enabled 
us to examine further moderating roles of coping style on the positive relationship 
between IBS symptom severity and psychological distress.  
 In the second and third hypotheses, the moderating association of active 
and avoidant coping style on the relationship between IBS symptom severity and 
psychological distress, in a clinical IBS population taking antispasmodic 
medication, were further examined. 
 More specifically, the second hypothesis explored whether active coping 
style moderated the relationship between irritable bowel symptom severity and 
distress.  Active coping did not have a significant first order effect on distress 
over and above demographic variables, perceived stress, and IBS related stressors.  
This indicated no direct relationship between level of active coping and level of 
psychological distress existed.  However, the interaction of active coping and IBS 
symptom severity was significantly associated with level of psychological distress 
in this population. 
 Furthermore, the third hypothesis explored whether avoidant coping style 
moderated the relationship between irritable IBS symptom severity and 
psychological distress.  Specifically, avoidant coping did have a significant first 
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order effect on distress over and above demographic and medical variables, 
perceived stress, and irritable bowel symptom severity.  Furthermore, the 
interaction of avoidant coping and IBS symptom severity was found to be 
significantly associated to levels of psychological distress in this population.   
 With further post-hoc analysis, IBS symptom severity was significantly 
and positively associated to both depression and trait anxiety.  Thus, the more IBS 
symptom severity a clinical IBS patient experienced, the higher their reported 
levels of depression and trait anxiety.  Active coping was independently and 
significantly associated with depression.  The interaction of active coping style 
and IBS symptom severity was significantly associated with levels of depression.  
Avoidant coping was significantly associated with both levels of depression and 
trait anxiety.  Furthermore, the relationship between IBS symptom severity and 
avoidant coping was significantly associated with levels of depression and trait 
anxiety.  The lack of a significant first order effect or interaction effect of active 
coping and IBS symptom severity on distress was contradictory to our hypothesis 
and current trends in the literature.     
 Tercyak, Lerman, Peshkin, Hughes, Main, Isaacs and Schwartz (2001) 
studied the effects of coping style on psychological distress (state anxiety) in 107 
women who were at increased risk for breast and/or ovarian cancers.  They found 
women who were more active in their coping behaviors (higher symptom 
monitoring) had increased levels of psychological distress while anticipating 
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genetic test results.  Therefore, when confronted with a illness such as IBS, 
individuals who vigilantly attend to threatening cues (i.e., active coping) such as 
constipation, gas, and diarrhea, are more likely to report heightened distress, than 
are individuals who tend to distract themselves (avoidant coping) when 
confronted with such IBS symptoms.  Therefore, future research may want to 
investigate trait anxiety in a clinical IBS population on antispasmodic medication 
specifically measuring symptom monitoring as is relates to psychological distress.  
10.1 Demographic Variables 
 Overall, 93% of the 98 participants were Caucasian, with 60% being 
female and 40% male with an average age of 55.  This is consistent with the 
current literature that suggests IBS is a condition that usually begins in people 
under the age of 45, who often seek treatment in their 40s and 50s (Hahn et al., 
1999).  Furthermore, forty-three percent of the participants held a college degree 
with 22% attaining a professional degree (J.D., Ph.D., M.D., M.B.A.).  Half of the 
participants reported an annual income between $52,000 and 120,000, with 20% 
of the sample reporting an annual income greater than $120,000.   
 Of note, 19% of individuals in this study endorsed a severe level of IBS 
symptomatology on the IBS-SS.  Current literature from both clinical and field 
samples indicates less than 5% of persons suffering with IBS report a severe level 
of physical symptomatology (Quigley, 2003).  This is particularly interesting, 
since all participants in this study were taking antispasmodic medication to 
 
Page 90 of 153  
Coping and Irritable Bowel Syndrome 
control a certain level of IBS symptomatology.  Due to this high level of reported 
physical symptoms, it may be essential to examine compliance of taking the 
prescribed antispasmodic medication in this clinical population.  If the patients 
were taking the medication as prescribed, it may be important to examine whether 
the medication is working for the indicated symptomatology.  One possible 
explanation is that patients may not be taking the medication long enough to 
attain the indicated results.  Furthermore, in this study participants reported a 
higher level of diarrhea dominate IBS symptomatology.  Therefore, the higher 
level of reported IBS symptom severity may be the result of other variables such 
as medication compliance, medication effectiveness or possibly an ineffective 
coping style.   
 Analyses of gender yielded varying results.  Gender differences in overall 
distress were not identified.  However, women endorsed a more active coping 
style as compared to males, but there was no difference between genders in 
avoidant coping style.  Previous studies have found disparity between genders in 
reporting symptoms of IBS due to sociocultural role stress in the United States 
(Shaw et al., 1997).  Most researchers have attributed this difference to 
psychosocial factors associated with illness behavior, since women are more 
likely to seek medical care in Western countries as compared to Eastern 
Countries, where no gender differences in treatment seeking are reported 
(Dancey, Hutton-Young, Moye, & Devins, 2002).  This sample was not quite 
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representative of the distribution of gender diagnoses typically found in IBS 
symptom reporting.  This study included a more evenly balanced distribution of 
women (60%) and men (40%) as compared to the overall literature.  In the current 
literature, women comprise approximately 75% of reported IBS sufferers in the 
United States (Heitkemper & Jarrett, 2001).   
 Seeing as we examined an already existing gastroenterologist population 
who were educated and endorsed a significant amount of perceived stress, these 
findings are consistent with the current literature.  In this sample, men may 
frequent GI practices more often due to the recent push for colonoscopies to rule 
out colon cancer (Hassler & Owyang, 2003).  Once in the gastrointestinal 
physician’s office, men may feel more comfortable discussing their IBS 
symptomatology.  More specifically, physicians at the Regional Gastrointestinal 
Consultants practice may screen more heavily for IBS than other GI practices, 
which current literature suggests.  Interestingly, time diagnosed with IBS was not 
associated with an increased level of psychological distress. 
 Though gender was not a significant predictor in this study, future 
research may want to examine the interaction of gender, coping style, 
psychological distress in a clinical versus non-clinical sample of persons 
diagnosed with IBS.  This may help shed light on the interrelationships among the 
above variables to assist in developing further treatment interventions. 
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 In this clinical IBS population, there were no significant differences in 
age, ethnicity or education across measures.  These findings are consistent with 
current literature in this field.  However, a positive relationship between age and 
time diagnosed with IBS was apparent.  Therefore, the older the participant was 
the longer they had reported suffering with IBS symptoms.  Furthermore, though 
this sample was mostly Caucasian, it has been acknowledged in the literature that 
there have not been significant differences found in symptom severity, quality of 
life, or distress.  Future studies may want to examine this more specifically in the 
future.  There was a small relationship between level of education and coping 
style.  Such that the more educated the participant the lower their avoidant coping 
style was.  In future research, it may be helpful to examine two separate 
populations of IBS patients.  Those with equal to or less than a high school 
education and those with advanced degrees and compare the two on symptom 
reporting and distress levels.    
 The findings in this study may be specific to our population, due to 
sociologic, economic and geographical variables.  However, the present study 
contained similar prevalence and demographics rates of IBS as compared to a 
large web-based survey conducted by US Bureau of the Census (2005).  
Approximately 31,829 people participated in the US Bureau of the Census (2005) 
IBS survey.  Of those surveyed 49% were male and 51% female.  Seventy-eight 
percent of the sample was Caucasian, 10% African American, seven percent 
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Hispanic and 5% another race.  In terms of education, 25% graduated high school, 
40% had some college and thirty percent had a bachelors degree or higher.  
Seventy-five percent were married and the median income was $59,400.  No 
differences were found between race, ethnicity, and socioeconomic status and 
severity or type of IBS experienced.   
10.2 Stressors and Distress: 
 As mentioned above, perceived stress significantly and positively related 
to psychological distress.  Indicating higher levels of perceived stress were 
associated with higher levels of psychological distress.  When considering this 
significant and positive association, IBS symptom severity had an independent 
positive and significant association with levels of distress.  Therefore, an increase 
in IBS symptom severity was associated with an increase in psychological 
distress.  The findings in this study are consistent with the current literature.  
Blanchard and colleagues (1987) found that patients with IBS who sought 
treatment were significantly more depressed and anxious, as measured by the 
Hamilton Scales, than either IBD patients or healthy controls who did not differ 
from each other.   
 In this clinical IBS population, as suggested by Blanchard and colleagues 
(1987), the measure of depression from the BDI was negatively skewed.  This 
indicates that most of the participants experienced several symptoms of 
depression in the past two weeks, while a small proportion of participants 
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experienced only a few symptoms of depression.  The few participants who did 
not endorse a significant amount of depressive symptoms, may have been due to 
several possibilities: they were not depressed, they were gaining relief from the 
antispasmodic medication, they experienced more anxious than depressive 
symptoms, or they may have been underreporting or minimizing depressive 
symptoms on the self-report measure. 
 However, both in the literature and this study, IBS patients displayed great 
frustration with the lack of control over their IBS symptoms and daily lives.  The 
unpredictability of when and where an exacerbation of IBS may occur, severity of 
symptoms, and lack of understanding and empathy for their illness by family, 
coworkers, and physicians may lead to feelings of disappointment, anger, and 
frustration.  Participants in this study reported high levels of IBS symptom 
severity as compared to the general population.  Only 16.3% of participants 
endorsed a score less than 75, indicating minimal distress, 34.7% endorsed mild 
IBS symptomatology (score 76-175), 29.6% (N=26) indicated moderate IBS 
symptom severity (score 176-300), and 19 participants (19.4%) endorsed severe 
IBS symptomatology (301-500).  Although this population was taking 
antispasmodic medication perhaps other variables may have contributed to high 
levels of IBS symptom severity.  
 The 16.3% of clinical IBS patients, who endorsed a score from 0-75/500 
on the IBS-SS indicating low levels of distress, may have experienced a positive 
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result from the antispasmodic medication consequently leading to a decrease in 
physical symptoms of IBS and subsequently psychological distress.  Furthermore, 
it was interesting to find that 19.4% of the participants in this study, taking 
antispasmodic medication, endorsed severe levels of IBS symptomatology (a 
score of 300-500 on the IBS-SS) as compared to less than 5% of other clinical 
IBS studies.  These findings suggest a third variable, such as an ineffective coping 
style, may be involved in this association.  Though the self-report measures 
utilized in this study contained good internal and external reliability and validity, 
it may be possible that if one were to report high on one question pertaining to 
distress and symptomatology, they would be likely to report high on all other 
questions pertaining to that specific aspect of distress.  Therefore, we may come 
up with an illusory correlation, tapping into over reporting of symptoms (possible 
somatization) and not a specific pattern or relationship of distress and IBS 
symptom severity. 
 However, when Dixon-Woods and Critchley (2000) asked clinical IBS 
patients how they felt about their IBS related symptoms responses included: 
“There is no control and people don’t understand that…. no one can”; “I think 
that part of the stress factor is the frustration of trying to figure out what’s coming 
next.”   
 The significant relationship between IBS symptom severity and distress 
indicates the importance for clinicians to explore the frequency and severity of 
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IBS stressors, as well as, assess symptoms of distress in patients treated medically 
for IBS.  The assessment of IBS symptom severity and distress in clinical IBS 
patients, may allow the clinician to address specific stressors that related to an 
increase in distress.  This may help reduce distress in IBS patients in several 
ways.  First the patient’s concern about this disorder “being all in their head” may 
be minimized through clinical validation of the pathophysiological relationship of 
the brain-gut axis.  Second, IBS patients often experience physical symptoms they 
may regard as embarrassing and difficult to discuss with others.  Third, addressing 
IBS related stressors and educating patients on ways to cope effectively with IBS 
related stressors may minimize the level of distress experienced and increase 
perceived control.   
 Additionally, clinicians have the ability to assess the diverse stressors 
clinical IBS patients experience as a way to recognize patients who may develop 
an increase in psychological distress.  Ineffective coping may play an integral role 
in the association between IBS symptom severity and psychological distress, 
which may negatively affect one’s quality of life.  Early identification and 
validation of the impact of IBS related symptoms and distress could lead to 
enhanced preventive measures in both medical and psychological treatments.  In 
turn, this could reduce ambiguity during treatment, decrease treatment time, and 
create a less stressful and more positive environment in which to address their 
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IBS symptoms, which may reduce psychological distress experienced by the 
clinical IBS patient. 
10.3 Coping Style and Distress 
 Avoidant coping was found to be significantly and positively associated 
with distress taking into account general perceived life stress.  Thus, clinical IBS 
patients who engaged in more avoidant behaviors, such as, denial, mental 
disengagement, behavioral disengagement and substance use, had an increase in 
psychological distress.  These findings have previously been noted in other 
medical and functional disorder populations.  Stowell et al. (2001) found 
significant interactions between avoidant coping and decrease in immune function 
on perceived stress.   
 There are various clinical implications involved with this finding.  It 
appears clinically important to assess one’s type of coping style as a potential 
predictor of distress.  If clinicians gain an increased understanding of a clinical 
IBS patient’s predominant type of coping style, it may help indicate whether the 
IBS patient will experience distress.  Avoidant coping can be described as a set of 
responses which represents a person’s immediate cognitive reactions when first 
confronted with a problem.  According to Lazarus and colleagues (1991), this 
refers to an individual’s beliefs, assumptions, appraisals, and expectations about 
their current situation and their resources available for managing it.  Clinical IBS 
suffers who utilize an avoidant coping style (e.g., alcohol, denial, or 
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counterproductive eating habits) may negatively influence physical health, IBS 
related symptoms, and psychological distress.  Therefore, future research may 
want to examine the relationship between cognitive appraisal, coping style, and 
pathophysiological reactivity (i.e., activation of the Brain-Gut Axis) in a clinical 
IBS population. 
Treatment aimed at training IBS patients to identify and modify their 
cognitive appraisal of situations, thoughts, and behaviors may increase patient’s 
awareness of the relationship between stressors, thoughts, and IBS related 
symptoms.  Understanding of the bi-directional neural pathways of the Brain-
Gut Axis may be effective in reducing distress in a treatment seeking IBS 
patient who may feel that IBS is “all in their head”.  This may lead to a sense of 
control managing IBS related stressors and subsequently overall perceived 
general life stressors.  In conclusion, clinical IBS patients who had a more 
avoidant coping style had higher levels of distress. 
 Though contradictory to our initial hypothesis, active coping style was not 
independently, significantly and inversely predictive of psychological distress.  
Thus, in this study, clinical IBS patients who endorsed a more active coping style 
did not report a decrease in psychological distress as supported in the literature.  
Active coping style, in previous studies, relates to a decrease in psychological 
distress in other medical and functional disorder populations, such as chronic 
fatigue syndrome (Jason et al., 2003).  Although, this finding was not statistically 
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significant, the study appears to be the first examining active versus avoidant 
coping in a clinical IBS population who took antispasmodic medication and 
warrants further research. 
10.4 Moderational Effects 
 In addition to examining the direct association between IBS symptom 
severity and distress, we further investigated whether specific coping styles 
(active & avoidant) differentially affected the influence of level of IBS symptom 
severity on distress.  Some research on coping suggests that successful from 
unsuccessful coping of a particular event may utilize a combination of both active 
and avoidant coping strategies (Moos, Brennan, & Fondacaro, 1990).  However, 
to our knowledge, no studies have jointly examined both the direct and indirect 
(moderational) influences of coping style in a clinical IBS population utilizing 
antispasmodic medication. 
10.4.1 Active Coping, Irritable Bowel Symptom Severity and Distress  
 The interaction between active coping and irritable bowel symptom 
severity significantly and positively explained a significant amount of variance in 
distress independent of the variance explained by the first order effects of the 
demographic and medical variables, perceived stress, and IBS symptom severity 
alone (see Table 5).  This significant and positive moderation warranted further 
investigation utilizing post-hoc probing of the interaction, as suggested by Aiken 
and West (1991), through computation of the simple slopes.  As can be seen in 
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Figure 10, low active coping was related to higher levels of distress at the mean 
reported symptom severity (score 186/500 moderate IBS symptom severity) and 
at severe levels of IBS symptom severity (score 291/500).  Individuals who 
endorsed a mean level of active coping experienced less distress then individuals 
utilizing a low level of active coping.  Furthermore, the relationship between low 
and mean active coping became inversely related to levels of distress at lower 
levels (-1 SD) of IBS symptom severity.  Thus, the more active coping skills a 
clinical IBS patient utilizes, the less psychological distress they will experience, 
specifically when experiencing moderate to severe IBS symptoms.  Interestingly, 
high levels of active coping did not differ in distress across levels of mild, 
moderate or severe IBS symptom severity.  This finding is not consistent with the 
current literature.  However, in clinical IBS patients utilizing a high level of active 
coping other variables may play a role in this association, such as perceived social 
support and/or high levels of optimism and hope.  This specific finding was not 
tested previously in IBS literature.  In future studies, it would be vital to explore 
associations between active coping, perceived social support, and high levels of 
optimism on the relationship between IBS symptom severity and psychological 
distress in a clinical IBS population.  This may enhance the understanding of 
effective strategies to reduce distress in the IBS patient. 
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10.4.2 Avoidant Coping, Irritable Bowel Symptom Severity and Distress 
 The interaction of avoidant coping and IBS symptom severity was 
significantly and positively associated to psychological distress taking into 
account general perceived life stress.  This did support our hypothesis and 
allowed for further post-hoc probing of this moderational effect as recommended 
by Aiken and West (1991).  As can be seen in Figure 12, high levels of avoidant 
coping were significantly related to higher levels of psychological distress, at 
mean levels (moderate IBS symptoms) and severe levels (+1 SD) of IBS 
symptom severity.  Mean levels of avoidant coping were significantly related to 
distress at moderate and high levels of IBS symptom severity.  Furthermore, 
clinical IBS patients who utilized a mean level of avoidant coping experienced 
less distress than individuals utilizing a high level of avoidant coping.   
Furthermore, low levels of avoidant coping were not significantly associated with 
distress across levels of IBS symptom severity.  Again, as with active coping 
style, there was no difference in distress levels at low (-1 SD) levels of IBS 
symptom severity.  These findings have several clinical implications.   
 The literature suggests that depending on the situational stressor, either 
active coping, avoidant coping or a combination of the two may be effective in 
managing a perceived stressor.  Though the interaction of IBS symptom severity 
and active and avoidant coping were both significantly associated with 
psychological distress.  Through a test for parallel slopes, it was found that 
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avoidant coping affects the relationship between levels of IBS symptom severity 
and psychological distress at significantly larger intervals than active coping.  
Therefore, a clinical IBS patient who endorses more avoidant coping strategies 
will experience higher levels of psychological distress more quickly then clinical 
IBS patients who utilize a more active coping style with the same level of IBS 
symptom severity.  This relationship appears to become more apparent at mean 
and high levels (+1 SD) of IBS symptom severity.   
 As previously discussed, Burnett and Drossman (2005) found the Brain-
Gut Axis to have a bi-directional association, such that increased abnormal 
muscle contractions, spasms, cramping, and pain can increase psychological 
distress through cognitive interpretation.  This psychological distress may develop 
through one’s poor coping abilities with IBS specific stressors.  Therefore, IBS 
becomes a vicious cycle where once the activation takes place the appraisal and 
coping with IBS symptomatology may help create an increase in distress thorough 
the utilization of less effective coping styles.  This is an important bi-directional 
role of emotions, coping, and pathophysiological activation of the Brain-Gut 
Axis. 
 Healthcare professionals ought to take a more preventive stance in terms 
of distress in this population, due to medical and psychological implications 
involved with distress and IBS.  It appears crucial to determine one’s potential 
distress level and coping style in the initial stages of a diagnosis of IBS, so 
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interventions can be implemented that may decrease distress.  The current 
findings suggest clinical trials conducted in the future should test whether 
psychoeducation on effective coping may be beneficial in minimizing level of 
distress and IBS symptom severity experienced in this population.  
10.5 Limitations 
 Due to the cross-sectional nature of this study design, it is ddifficult to 
make causal inference.  This study provides a “snapshot” of the individual’s 
situation which may provide differing results if another time frame had been 
chosen (Bland M., 2001).  Furthermore, implications of confirmed causal or 
directional relationships cannot be confirmed.  That is, it is not certain whether 
active and avoidant coping styles increased distress, or vice versa, although a 
comprised of a mostly educated, middle-class, Caucasian, married population.  
Therefore, the results suggest a directional relationship in this study. 
 The population of this study of this study represent the majority of the 
population in search of clinical treatment for IBS and the population in need 
further research in the IBS field (Shaw et al., 1997) and are representative of the 
2005 US Bureau of the Census web-based survey on the prevalence and 
demographics of IBS.  The degree of distress and IBS stressors experienced by 
diverse ethnicities and cultures is comparable in the current literature, though 
these differ in the relevant meaning of psychosocial factors associated with illness 
behavior (Dancey, Hutton-Young, Moye, & Devins, 2002).  A study conducted by 
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Gralnek, Hayes, Kilbourne, Chang, & Mayer (2006) found there were no 
significant differences in Caucasian versus non-Caucasian individuals on health 
related quality of life.  However, non-Caucasian patients experienced an increase 
role limitations and physical pain associated with IBS.  It would be interesting to 
conduct a study examining Eastern versus Western cultures intercontinental on 
IBS symptom severity and related psychological distress.  More efforts to develop 
and investigate cross-cultural studies with distress and IBS are called for.  
However, since this study focused mainly on this select clinical IBS population 
receiving antispasmodic medications, reinforces the internal validity of the study. 
 Another possible limitation to the study is the concept of a third variable 
or construct that may be the result of any of the significant results reported.  
Although, this study controlled for variables that may confound the results, there 
exists the possibility of a potential third variable not controlled for in this study 
such as medication compliance or medication effectiveness.  Self-report 
measures, by the very nature of their design, are naturally limited by possible 
under or over reporting of IBS symptoms or psychological distress for socially 
desirability.  This in turn, may mask the level of symptoms that truly exist.  While 
the use of an IBS symptom severity specific measure and measures with good 
psychometric properties helps to control for this limitation, future research should 
consider complementing the self-report measures with other methods such as 
certain pathophysiological medical tests and a clinical interview. 
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10.6 Implications and Future Research 
 Varieties of implications emerge from the results of the present study.  
Due to the need for psychological services and empirically validated treatments in 
the clinical IBS population treated with antispasmodic medication, this study may 
be regarded as an initial step in identifying a foundation for future treatment 
interventions in coping, IBS, and distress.  An intervention, in changing one’s 
coping style from avoidant to more active in nature, could improve both 
psychological health and decrease IBS related symptoms in a clinical IBS 
population.  This intervention may lead to a decrease in the degree of invasive and 
embarrassing procedures conducted number of lost work and school days, and 
overall cost and time to both patients and the medical community.  Future 
research should explore these constructs as they relate to overall social support in 
persons experiencing IBS symptoms and distress.   
 It is imperative for research in this field to move beyond cross-sectional, 
descriptive studies and recognize predictors of psychological and IBS symptom 
outcomes with longitudinal and experimental designs.  This population could 
benefit from longitudinal treatment outcome studies to expand the understanding 
of predictors and causal relationships, as well as, apply empirically validated 
treatments.  It would be beneficial to examine the preventive measures aimed at 
treating patients when they initially seek treatment for IBS to intercept the 
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activation of the bi-directional Brain-Gut Axis, and improve overall coping in this 
population.  
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  CHAPTER 11: SUMMARY AND CONCLUSION 
 
In the past 20 years, although the identification of empirically supported 
treatment options is rather new to gastrointestinal, physiological, and 
psychological fields, the professional community does recognize IBS as syndrome 
that has treatment options.  Many individuals suffering with IBS report increased 
distress levels and a significant disruption in quality of living.  The literature 
frequently suggests persons with IBS encounter a significant level of physical 
stressors and psychological distress.  Research concentrating on the question of 
why some persons with IBS are clinically distressed and others are not, and the 
role of coping style to IBS related stressors, is considered necessary to provide 
effective treatment interventions in this population.  This may further decrease the 
financial cost, time, invasive treatments and medical tests IBS patients must 
endure.   
 The present study explored the relationships between IBS related stressors, 
perceived stress, coping, and distress in clinical IBS patients receiving 
maintenance antispasmodic medication.  Specifically, persons who reported 
greater IBS related symptoms reported increased levels of distress.  Those persons 
who utilized a more avoidant coping style had increase in distress compared with 
persons who utilized a more active coping style.  The interaction of active and 
avoidant coping styles were independently and significantly associated with the 
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relationship between IBS symptom severity and distress.  Furthermore, clinical 
IBS patients who utilized a more avoidant coping style were found to have a 
stronger moderating role between IBS symptom severity and psychological 
distress.  This was the first study known to this author to incorporate an IBS 
symptom severity and coping style measure in a sample of clinical IBS patients 
receiving a maintenance antispasmodic therapy.  
 The clinical implications of this study contribute significantly to the 
current IBS literature.  The above information on IBS related symptom severity, 
perceived stress, coping and distress can be utilized to assess IBS suffers and 
develop personalized treatment interventions intended to decrease distress, reduce 
IBS symptom severity, and improve overall active coping skills.  This in turn may 
decrease the frequency and duration of IBS, as well as increase quality of life.  
These results suggest that future research should investigate the role coping style 
plays in a longitudinal treatment intervention to assess impact on IBS, distress, 
and quality of life. 
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   APPENDIX A: MANNING CRITERIA 
 
 
 
 
Manning Criteria for Diagnosing Symptoms of IBS 
 
 
1. Pain 
2. looser stools at onset of pain 
3. more frequent bowel movements at onset of pain 
4. pain (often) eased after bowel movement 
5. visible distension (bloating) 
6. feelings of distention 
7. mucus per rectum 
8. feeling (often) of incomplete emptying 
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   APPENDIX B: ROME CRITERIA I 
 
 
 
 
Rome I Criteria for Diagnosing Symptoms of IBS 
 
At least three months continuous or recurrent symptoms of 
 
1. Abdominal pain or discomfort that is  
a. Relieved by defecation 
b. And/or associated with a change in frequency in stool 
c. And/or associated with a change in the consistency of stool 
 
2. Accompanied by two or more of the following, at least a quarter of 
occasions or days: 
a. Altered stool frequency (more than three bowel movements per 
day or fewer than three bowel movements per week) 
b. Altered stool form (lumpy/hard or loose/watery stool) 
c. Altered stool passage (straining, urgency, or feeling of incomplete 
evacuation) 
d. Passage of mucus 
e. Bloating or feeling of abdominal distention 
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   APPENDIX C: ROME CRITERIA II 
 
 
 
 
Rome II Criteria for Diagnosing IBS 
 
At least 12 weeks, which do not need to be consecutive, in the preceding 12 
months: 
 
1. Abdominal discomfort or pain 
2. accompanied by two or more of the following: 
a. relieved by defecation 
b. onset associated with change in stool frequency/ and/or 
consistency 
c. onset associated with change in form or appearance of stool 
 
Supportive symptoms of the irritable bowel syndrome: 
 
1. fewer than three bowel movements a week 
2. more than three bowel movements a day 
3. hard or lumpy stools 
4. straining during a bowel movement 
5. urgency (having to rush to have a bowel movement) 
6. loose (mushy) stools 
7. feeling of incomplete bowel movement 
8. passing mucus during a bowel movement 
 abdominal fullness, bloating, or swelling 
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      APPENDIX D: THE ENTERIC NERVOUS SYSTEM 
 
 Two ganglionated neural plexuses in the gut wall which form one 
of the three major divisions of the autonomic nervous system.  The enteric 
nervous system innervates the gastrointestinal tract, the pancreas, and the 
gallbladder.  It contains sensory neurons, interneurons, and motor neurons. 
Thus the circuitry can autonomously sense the tension and the chemical 
environment in the gut and regulate blood vessel tone, motility, secretions, 
and fluid transport.  The system is itself governed by the central nervous 
system and receives both parasympathetic and sympathetic innervations. 
(Kandel, Schwartz, & Jessel, Principles of Neural Science, 3d ed, p766)  
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  APPENDIX E: MODEL OF MODERATION 
 
 
 
DISTRESS 
 
Anxiety (STAI) 
Depression (BDI-II) 
COPING 
Active (COPE) 
Avoidant (COPE) 
STRESSORS 
 
IBS-Specific Stress 
(IBS-SS) 
 
- 
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 APPENDIX F: THE COPE SCALES 
 
 
 
Subscale Definition 
Active coping Taking action or exerting efforts to remove or circumvent the stressor 
Planning Thinking about how to confront the stressor, planning one's active coping efforts 
Seeking Instrumental Social 
Support Seeking assistance, information, or advice about what to do 
Seeking Emotional Social 
Support Getting sympathy or emotional support from someone 
Suppression of Competing 
Activities 
Suppressing one's attention to other activities in which one 
might engage in order to concentrate more completely on 
dealing with the stressor 
Religion Increased engagement in religious activities 
Positive Reinterpretation and 
Growth 
Making the best of the situation by growing from it or viewing 
it in a more favorable light 
Restraint Coping Coping passively by holding back one's coping attempts until they can be of use 
Resignation/ Acceptance Accepting the fact that the stressful event has occurred and is real 
Focus on and Venting of 
Emotions 
An increased awareness of one's emotional distress, and a 
concomitant tendency to ventilate or discharge those feelings 
Denial An attempt to reject the reality of the stressful event 
Mental Disengagement 
Psychological disengagement from the global with which the 
stressor is interfering, through daydreaming, sleep, or self-
distraction 
Behavioral Disengagement Giving up, or withdrawing effort from, the attempt to attain the goal with which the stressor is interfering 
Alcohol/ Drug Use Turning to the use of alcohol and other drugs as a way of disengaging from the stressor 
Humor Making jokes about the stressor 
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APPENDIX G: DSM-IV-TR CRITERIA OF SUBSTANCE ABUSE 
 
A.  A maladaptive pattern of substance use leading to clinically significant impairment or    
distress, as manifested by one (or more) of the following, occurring during a given 12-
month period: 
 (1)  Substance use resulting in a recurrent failure to fulfill work, school, or home    
       obligations (e.g., work absences, substance-related school suspensions, 
       neglect of children or household) 
 (2)  Substance use in physically hazardous situations such as driving or     
       operating machinery  
 (3)  Substance use resulting in legal problems such as drug-related arrests 
 (4)  Continued substance use despite having persistent or recurrent social or        
       interpersonal problems caused or exacerbated by the effects of the            
       substance (e.g.,, arguments with spouse about consequences of     
        intoxication, physical fights) 
B.  The symptoms have never met the criteria for Substance Dependence for this            
class of substance 
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 APPENDIX H:  IRRITABLE BOWEL SYNDROME SEVERITY  
       SCORING SYSTEM 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 129 of 153  
Coping and Irritable Bowel Syndrome 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 130 of 153  
Coping and Irritable Bowel Syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 131 of 153  
Coping and Irritable Bowel Syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 132 of 153  
Coping and Irritable Bowel Syndrome 
  APPENDINX I: PERCEIVED STRESS SCALE 
Perceived Stress Scale 
The questions in this scale ask you about your feelings and thoughts during the last month.  In 
each case, you will be asked to indicate by circling how often you felt or thought a certain 
way. 
 
Name ____________________________________________________  Date _________ 
 
Age ________  Gender (Circle):    M    F            Other  
 
0 = Never     1 = Almost Never     2 = Sometimes     3 = Fairly Often     4 = Very Often 
1. In the last month, how often have you been upset 
because of something that happened unexpectedly?........................................................   
2. In the last month, how often have you felt that you were unable 
to control the important things in your life? ....................................................................   
3. In the last month, how often have you felt nervous and “stressed”? ...............................   
4. In the last month, how often have you felt confident about your ability 
to handle your personal problems? ..................................................................................   
5. In the last month, how often have you felt that things 
were going your way?......................................................................................................   
6. In the last month, how often have you found that you could not cope 
with all the things that you had to do? .............................................................................   
7. In the last month, how often have you been able 
to control irritations in your life? .....................................................................................   
8. In the last month, how often have you felt that you were on top of things? ....................   
9. In the last month, how often have you been angered 
because of things that were outside of your control?.......................................................   
10. In the last month, how often have you felt difficulties 
were piling up so high that you could not overcome them? ............................................   
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      APPENDIX J: DEMOGRAPHIC SHEET 
PIN No.______ 
Please circle your answers below 
 
1.  Age   18-24  25-34  35-44  45-54   
   55-64  65-74  75+ 
 
2. Gender Male  Female 
 
3.  Education Level 6th  8th 10th  12th (high school)     2 yr college 
   4yr college professional degree  
 
4.  Marital Status        Single      Married    Divorced   Separated      
Widowed  
 
5.  Who do you currently live with?       Self         Spouse        Significant other       
     Children #_______     Other family members____________      Pet__________ 
 
6.  Ethnicity            Caucasian       African American     Hispanic       Native American 
   Pacific Islander         Other    
7.  Religion Please identify your religion____________________________________ 
Are you currently a member of a religious organization?____Yes_____No 
How often do you attend/ practice religious services?_________________ 
 
8.  Household income less than 16,000    16,000-33,999   34,000-51,999 
  52,000-69,999    70,000-89,999     90,000-119,999    120,000-149,999 
  150,000-199,999       200,000-249,000 250,000+ 
 
9.  Occupation ____________________________      Hours per week_____________ 
 
Substance Use History 
Please circle your answer.   
10.  Do you smoke cigarettes? Yes No   
11.  Do you drink caffeine     Yes     No  
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PIN No._______ 
Psychological History 
12.  Do you have a history of inpatient psychiatric hospitalizations?         Yes   No 
13.  Do you have a history of outpatient psychological or psychiatric services?   Yes  No 
14.  If yes, are you currently in therapy?  Yes No 
15.  Are you taking any psychotropic medications? Yes No 
16.  If yes, please indicate for what, type (name) and dosage 
________________________________________________________________________
________________________________________________________________________
______________________________________________________ 
 
General Medical History 
 
17.  Are you seeing any doctor on a regular basis?  Yes  No 
 If yes, please indicate what type of doctor and why. 
________________________________________________________________________
________________________________________________________________________
______________________________________________________ 
 
18.  Please indicate what kind of medication/ herbs/ vitiams you take on a regular basis 
and why 
________________________________________________________________________
________________________________________________________________________
______________________________________________________ 
 
19.  Are you on any special food diet either prescribed or voluntary?  
Yes No 
If yes, please indicate what type of diet and why 
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PIN No._______ 
 
IBS Specific History 
 
20.  What is your current GI diagnosis?________________________________________ 
21.  What current treatment are you receiving for this?____________________________ 
________________________________________________________________________ 
________________________________________________________________________ 
22.  How long have you been diagnosed with this GI disorder?_____________________ 
________________________________________________________________________ 
________________________________________________________________________ 
23.  What are your current symptoms of your GI disorder?_________________________ 
________________________________________________________________________ 
________________________________________________________________________ 
________________________________________________________________________ 
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          TABLES 
 
Table 1.  Descriptive Statistics for Independent and Dependent Variables (N=98) 
 
 
 
Measure Mean 
(Raw) 
Standard 
Deviation
Minimum Maximum Skew Kurtosis 
BDI 11.27 8.69 .00 41 1.20 1.79 
PSS 21.14 4.76 6 32 -.431 .809 
IBS-SS 185.92 105.09 .00 385 .130 -.772 
STAI-S 41.88 10.49 23 70 .233 -.69 
STAI-T 39.91 10.47 22 70 .429 -.69 
Active 70.21 16.41 28 106 -.218 -.112 
Avoidant 63.13 12.98 32 99 .491 .082 
Combined 
Distress 
0 1.0 -1.56 3.01 .670 .003 
 
 
 
Note. BDI = Beck Depression Inventory.  PSS = Perceived Stress Scale.  IBS-SS 
= Irritable Bowel Syndrome Symptom Severity Scale.  STAI = State Trait 
Anxiety Inventory. Active = Active Coping Style measured by scales in the 
COPE.  Avoidant = Avoidant Coping Style measured by scales in the COPE.   
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Table 2.  Intercorrelations between Independent and Dependent Variables 
 
 
 
 1. 2. 3. 4 
1. Distress     
2. PSS .34**    
3. IBS-SS .35** .12   
4. Active -.12 .10 -.23*  
5. Avoidant .18 .12 -.12 .51** 
 
  *Correlation is significant at the 0.05 level 
**Correlation is significant at the 0.01 level 
 
 
 
Note.  PSS = Perceived Stress Scale.  IBS-SS = Irritable Bowel Syndrome 
Symptom Severity Scale.  Active = Active Coping Style measured by scales in 
the COPE.  Avoidant = Avoidant Coping Style measured by scales in the COPE.   
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Table 3.  Intercorrelations between Demographic and both Independent and 
Dependent Variables 
 
 
 
 Age Gender Time Diagnosed 
Combined 
Distress 
-.27** .06 .03 
PSS -.02 .12 .04 
IBS-SS -.19 .16 .22* 
Active .24* .20* -.06 
Avoidant .09 -.16 -.09 
 
  *Correlation is significant at the 0.05 level 
**Correlation is significant at the 0.01 level 
 
 
 
Note.  PSS = Perceived Stress Scale.  IBS-SS = Irritable Bowel Syndrome 
Symptom Severity Scale.  Active = Active Coping Style measured by scales in 
the COPE.  Avoidant = Avoidant Coping Style measured by scales in the COPE.   
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Table 4.  Coefficients of Regression of Distress on Stressors (PSS and IBS-
related) 
 
 
 
Variables Standardized Beta t Sig.    
Age -.23 -2.30 .024 
Gender -.041 -.444 .658 
Time .035 .348 .729 
PSS .304 3.34 .001 
IBS-SS .263 2.7 .008 
 
 
 
Note.  Time = Time Diagnosed with IBS.  PSS = Perceived Stress Scale.  IBS-SS 
= Irritable Bowel Syndrome Symptom Severity Scale.   
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Table 5.  Coefficients of Regression of Distress on Stressors (PSS and IBS-
Related) and Active Coping Style 
 
 
 
Variables Standardized Beta t Sig. 
Age -.222 -2.20 .031 
Gender -.039 -.415 .679 
Time .050 .502 .617 
PSS .309 3.41 .001 
IBS-SS .241 2.45 .016 
Active -.071 -.715 .476 
XIBSActive .186 2.04 .044 
 
 
 
Note.  Time = Time Diagnosed with IBS.  PSS = Perceived Stress Scale.  IBS-SS 
= Irritable Bowel Syndrome Symptom Severity Scale.  Active = Active Coping 
Style measured by scales in the COPE.  XIBSActive = Interaction between Active 
Coping Style and IBS Symptom Severity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 141 of 153  
Coping and Irritable Bowel Syndrome 
Table 6.  Coefficients of Regression of Distress on Stressors (PSS and IBS-
Related) and Avoidant Coping Style 
 
 
 
Variables Standardized Beta t Sig. 
Age -.24 -2.55 .013 
Gender -.003 -.030 .976 
Time .064 .675 .502 
PSS .238 2.68 .009 
IBS-SS .270 2.92 .004 
Avoidant .217 2.45 .016 
XIBSAvoidant .221 2.54 .013 
 
 
 
Note.  Time = Time Diagnosed with IBS.  PSS = Perceived Stress Scale.  IBS-SS 
= Irritable Bowel Syndrome Symptom Severity Scale.  Avoidant = Avoidant 
Coping Style measured by scales in the COPE.  XIBSAvoidant = Interaction 
between Avoidant Coping Style and IBS Symptom Severity 
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Table 7.  Variance and Significance of Regression of Depression, State and Trait 
Anxiety on Stressors (PSS and IBS-Related), and Coping Style (active and 
avoidant) 
 
 
 
Variables BDI-II STAI-S STAI-T 
Overall variance 
IBS-SS 
17.7%, p=.025 21.4%, p=.019 25.5%, p=.014 
Active Coping 17.8%, p<.01 22.0%, p=.389 25.4%, p=.620 
IBSxACT 22.8%, p=.018 23.2%, p=233 28.1%, p=.072 
Avoidant Coping 26.1%, p=.002 21.9%, p=.455 29.0%, p=.031 
IBSxAVD 30.6%, p=.017 24.1%, p=.109 34.2%, p=.009 
 
Bold Type = Significant 
 
 
Note.   IBS-SS = Irritable Bowel Symptom Severity Scale.  Avoidant = Avoidant 
Coping Style measured by scales in the COPE.  IBSxACT = Interaction between 
Active Coping Style and IBS Symptom Severity. IBSxAVD = interaction 
between Avoidant Coping Style and IBS Symptom Severity 
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              FIGURES 
 
 
 
Figure 3.  Frequency Table of Irritable Bowel Symptom Severity in a Clinical IBS 
Population (N=98) 
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Figure 4.   Frequency of Perceived Stress in a Clinical IBS Population (N=98) 
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Figure 5.  Correlation between IBS Symptom Severity and Distress 
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Figure 6.  Correlation between Avoidant Coping and Distress 
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Figure 7.  Correlation between Active Coping and Distress 
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Figure 8.  Frequencies of active coping by gender (N=98) 
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Figure 9.  Regression Equations for the Relationship between IBS Symptom 
Severity and Active Coping on Distress 
 
 
 
Mean X (IBS-SS) = 0, SD = +/- .999  
 
Mean Z (active coping) = 0, SD = +/- 1.00  
 
Regression Equations 
 
ZH: Y = 0.086X – 0.1023 
ZM: Y = 0.241X – 0.031 
ZL:  Y = 0.396X + 0.0403 
  Z High  
(16.41) 
Z Mean  
(0) 
Z Low 
 (-16.41) 
 X High 
(0.999) 
Y= -0.0163 Y= 0.210 Y= 0.4363 
 
 X Mean  
(0) 
Y= -0.1023 Y= -0.031 Y= .0403 
 
 X Low 
(-0.999) 
Y= -0.1882 Y= -0.272 Y= -0.3557 
 
 
 
 
T-Test for Simple Slopes 
 
 
 slope SE t-test 
High Active Coping 0.86 0.1198 0.7174 
Mean Active Coping 0.241 0.0984 2.450 
Low Active Coping 0.396 0.1283 3.086 
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Figure 10.  The Relationship between IBS Symptom Severity and Active Coping 
on Distress 
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Figure 11.  Regression Equations for the Relationship between IBS Symptom 
Severity and Avoidant Coping on Distress 
 
 
Mean X (IBS-SS) = 0,  SD = +/- .999 
 
Mean Z (avoidant coping) = 0,  SD = +/- 1.00  
 
Regression Equations 
 
ZH: Y = 0.492X + 0.115 
ZM: Y = 0.27X – 0.102 
ZL:  Y = 0.048X + 0.319 
 
 
 Z High  
(12.98) 
Z Mean  
(0) 
Z Low  
(-12.98)  
X High 
(105.1) 
Y= 0.607 Y= 0.168 Y= -0.271  
 
X Mean  
(0) 
Y= 0.115 Y= -0.102 Y= -0.319  
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T-Test for Simple Slopes 
 
 
 slope SE t-test 
High Avoidant Coping 0.492 0.1249 3.937 
Mean Avoidant Coping 0.270 0.0927 2.913 
Low Avoidant Coping 0.048 0.1298 0.3697 
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Figure 12.  The Relationship between IBS Symptom Severity and Avoidant 
Coping on Distress 
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